New! View global litigation for patent families

US20040172089A1 - Fully implantable miniature neurostimulator for stimulation as a therapy for epilepsy - Google Patents

Fully implantable miniature neurostimulator for stimulation as a therapy for epilepsy Download PDF

Info

Publication number
US20040172089A1
US20040172089A1 US10057115 US5711502A US2004172089A1 US 20040172089 A1 US20040172089 A1 US 20040172089A1 US 10057115 US10057115 US 10057115 US 5711502 A US5711502 A US 5711502A US 2004172089 A1 US2004172089 A1 US 2004172089A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
nerve
stimulation
stimulator
trigeminal
microstimulator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US10057115
Other versions
US6788975B1 (en )
Inventor
Todd Whitehurst
James McGivern
Janusz Kuzma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Neuromodulation Corp
Original Assignee
Boston Scientific Neuromodulation Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37205Microstimulators, e.g. implantable through a cannula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36064Epilepsy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526Head electrodes
    • A61N1/0529Electrodes for brain stimulation

Abstract

A small implantable stimulator(s) with at least two electrodes is small enough to have the electrodes located adjacent to a nerve structure at least partially responsible for epileptic seizures. The small stimulator provides a means of stimulating a nerve structure(s) when desired, and may be implanted via a minimal surgical procedure.

Description

  • [0001]
    The present application claims the benefit of U.S. Provisional Patent Application Serial No. 60/265,008, filed Jan. 30, 2001, which application is incorporated herein by reference in its entirety.
  • FIELD OF THE INVENTION
  • [0002]
    The present invention generally relates to implantable stimulator systems, and more particularly relates to an implantable stimulator system utilizing one or more implantable microstimulators for treating epilepsy.
  • BACKGROUND OF THE INVENTION
  • [0003]
    Epilepsy is characterized by a tendency to recurrent seizures that can lead to loss of awareness, loss of consciousness, and/or disturbances of movement, autonomic function, sensation (including vision, hearing and taste), mood, and/or mental function. Epilepsy afflicts 1-2% of the population in the developed world. The mean prevalence of active epilepsy (i.e., continuing seizures or the need for treatment) in developed and undeveloped countries combined is estimated to be 7 per 1,000 of the general population, or approximately 40 million people worldwide. Studies in developed countries suggest an annual incidence of epilepsy of approximately 50 per 100,000 of the general population. However, studies in developing countries suggest this figure is nearly double at 100 per 100,000.
  • [0004]
    Epilepsy is often but not always the result of underlying brain disease. Any type of brain disease can cause epilepsy, but not all patients with the same brain pathology will develop epilepsy. The cause of epilepsy cannot be determined in a number of patients; however, the most commonly accepted theory posits that it is the result of an imbalance of certain chemicals in the brain, e.g., neurotransmitters. Children and adolescents are more likely to have epilepsy of unknown or genetic origin. The older the patient, the more likely it is that the cause is an underlying brain disease such as a brain tumor or cerebrovascular disease.
  • [0005]
    Trauma and brain infection can cause epilepsy at any age, and in particular, account for the higher incidence rate in developing countries. For example, in Latin America, neurocysticercosis (cysts on the brain caused by tapeworm infection) is a common cause of epilepsy; in Africa, AIDS and its related infections, malaria and meningitis, are common causes; in India, AIDS, neurocysticercosis and tuberculosis, are common causes. Febrile illness of any kind, whether or not it involves the brain, can trigger seizures in vulnerable young children, which seizures are called febrile convulsions. About 5% of such children go on to develop epilepsy later in life. Furthermore, for any brain disease, only a proportion of sufferers will experience seizures as a symptom of that disease. It is therefore suspected that those who do experience such symptomatic seizures are more vulnerable for similar biochemical/neurotransmitter reasons.
  • BRIEF SUMMARY OF THE INVENTION
  • [0006]
    The invention disclosed and claimed herein provides means for chronically stimulating a trigeminal ganglion or ganglia, a trigeminal nerve(s), or branch(es) of a trigeminal nerve(s) with a miniature implantable neurostimulator that can be implanted with a minimal surgical procedure. This invention also provides means for chronically stimulating a greater occipital nerve(s), lesser occipital nerve(s), third occipital nerve(s), facial nerve(s), glossopharyngeal nerve(s), or a branch(es) of any of these neural structures with a miniature implantable neurostimulator that can be implanted with a minimal surgical procedure. Electrical stimulation of such targets may provide significant therapeutic benefit in the management of epilepsy.
  • [0007]
    To treat epilepsy, a miniature implantable neurostimulator, such as a Bionic Neuron (also referred to as a BION™ microstimulator) may be implanted via a minimal surgical procedure (e.g., injection or small incision) adjacent to a trigeminal ganglion or ganglia, trigeminal nerve(s), branch(es) of a trigeminal nerve(s) (e.g., ophthalmic nerve(s), maxillary nerve(s), and/or mandibular nerve(s)), or branch(es) of any of these neural structures. A BION may additionally or alternatively be implanted adjacent to a greater occipital nerve(s), a lesser occipital nerve(s), a third occipital nerve(s), a facial nerve(s), a glossopharyngeal nerve(s), or a branch(es) of any of these neural structures to treat epilepsy.
  • [0008]
    A microstimulator may be implanted via injection and/or via endoscopic means. A more complicated surgical procedure may be required for sufficient access to a particular nerve (e.g., a nerve surrounded by scar tissue) or for purposes of fixing the neurostimulator in place. A single microstimulator may be implanted, or two or more microstimulators may be implanted to achieve greater stimulation of one or more nerves.
  • [0009]
    The microstimulator used with the present invention possesses one or more of the following properties, among others:
  • [0010]
    at least two electrodes for applying stimulating current to surrounding tissue;
  • [0011]
    electronic and/or mechanical components encapsulated in a hermetic package made from biocompatible material(s);
  • [0012]
    an electrical coil or other means of receiving energy and/or information inside the package, which receives power and/or data by inductive or radio-frequency (RF) coupling to a transmitting coil placed outside the body, thus avoiding the need for electrical leads to connect devices to a central implanted or external controller;
  • [0013]
    means for receiving and/or transmitting signals via telemetry;
  • [0014]
    means for receiving and/or storing electrical power within the microstimulator; and
  • [0015]
    a form factor making the microstimulator implantable via a minimal surgical procedure.
  • [0016]
    A microstimulator may operate independently, or in a coordinated manner with other implanted devices, or with external devices. For instance, a microstimulator may incorporate means for sensing epilepsy, which it may then use to control stimulation parameters in a closed loop manner. The sensing and stimulating means may be incorporated into a single microstimulator, or a sensing means may communicate sensed information to at least one microstimulator with stimulating means.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0017]
    The above and other aspects of the present invention will be more apparent from the following more particular description thereof, presented in conjunction with the following drawings wherein:
  • [0018]
    [0018]FIG. 1A depicts various nerve branches dorsal to the trigeminal nerve and nearby bony structures;
  • [0019]
    [0019]FIG. 1B illustrates the trigeminal nerve, and nerve branches dorsal and proximal to the trigeminal nerve;
  • [0020]
    [0020]FIG. 2A illustrates various autonomic nerves in the head;
  • [0021]
    [0021]FIG. 2B depicts various nerves and muscles of the back of the head and neck;
  • [0022]
    [0022]FIG. 3 illustrates an exemplary embodiment of a stimulation system of the present invention;
  • [0023]
    [0023]FIG. 4 illustrates preferred external components of the invention; and
  • [0024]
    [0024]FIG. 5 depicts a system of implantable devices that communicate with each other and/or with external control/programming devices.
  • [0025]
    Corresponding reference characters indicate corresponding components throughout the several views of the drawings.
  • DETAILED DESCRIPTION OF THE INVENTION
  • [0026]
    The following description is of the best mode presently contemplated for carrying out the invention. This description is not to be taken in a limiting sense, but is made merely for the purpose of describing the general principles of the invention. The scope of the invention should be determined with reference to the claims.
  • [0027]
    Recent studies in both developed and developing countries have shown that up to 70% of newly diagnosed children and adults with epilepsy can be successfully treated (i.e., complete control of seizures for several years) with anti-epileptic drugs. After two to five years of successful treatment, drugs can be withdrawn in about 70% of children and 60% of adults without the patient experiencing relapses. However, up to 30% of patients are refractory to medication. There is evidence that the longer the history of epilepsy, the harder it is to control. The presence of an underlying brain disease typically results in a worse prognosis in terms of seizure control. Additionally, partial seizures, especially if associated with brain disease, are more difficult to control than generalized seizures.
  • [0028]
    Patients suffering from epilepsy may undergo surgery to remove a part of the brain in which the seizures are believed to arise, i.e., the seizure focus. However, in many patients a seizure focus cannot be identified, and in others the focus is in an area that cannot be removed without significant detrimental impact on the patient. For example, in temporal lobe epilepsy, patients may have a seizure focus in the hippocampi bilaterally. However, both hippocampi cannot be removed without devastating impacts on long-term memory. Other patients may have a seizure focus that lies adjacent to a critical area such as the speech center.
  • [0029]
    Vagus nerve stimulation (VNS) has been applied with partial success in patients with refractory epilepsy. In this procedure, an implantable pulse generator (IPG) is implanted in the patient's thorax, and an electrode lead is routed from the IPG to the left vagus nerve in the neck. Helix-shaped stimulation and indifferent electrodes are attached to the vagus nerve via an invasive surgical process that requires the carotid sheath to be fully exposed. Based on a number of studies, approximately 5% of patients undergoing VNS are seizure-free, and an additional 30-40% of patients have a greater than 50% reduction in seizure frequency.
  • [0030]
    In addition to this relatively low efficacy, VNS may lead to significant side effects. The vagus nerve provides parasympathetic innervation to the cardiac tissue, and thus VNS may lead to bradycardia, arrhythmia, or even graver cardiac side effects. In fact, VNS systems may only be used on the left vagus nerve, as the right vagus nerve contributes significantly more to cardiac innervation. Additionally, VNS may interfere with proper opening of the vocal cords, which has led to hoarseness and shortness of breath in a significant number of VNS patients.
  • [0031]
    The exact mechanism of action of VNS is unknown. The nucleus of tractus solitarius (NTS; a.k.a., nucleus of the solitary tract) is a primary site at which vagal afferents terminate. Because afferent vagal nerve stimulation has been demonstrated to have anticonvulsant effects, it is likely that changes in synaptic transmission in the NTS can regulate seizure susceptibility. To demonstrate this, Walker, et al. (“Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius,” Epilepsia, 1999 August) applied muscimol, an agonist of the inhibitory neurotransmitter GABA, to the NTS in a murine model of epilepsy. Muscimol applied to the NTS attenuated seizures in all seizure models tested, whereas muscimol applied to adjacent regions of NTS had no effect. Additionally, bicuculline methiodide, a GABA antagonist, injected into the NTS did not alter seizure responses. Finally, anticonvulsant effects were also obtained with application of lidocaine, a local anesthetic, into the NTS. Unilateral injections were sufficient to afford seizure protection. Walker, et al. concludes that inhibition of the NTS outputs enhances seizure resistance in the forebrain and provides a potential mechanism for the seizure protection obtained with vagal stimulation.
  • [0032]
    The NTS sends fibers bilaterally to the reticular formation and hypothalamus, which are important in the reflex control of cardiovascular, respiratory, and gastrointestinal functions. The NTS also provides input to the dorsal motor nucleus of the vagus, which enables the parasympathetic fibers of the vagus nerve to control these reflex responses. The NTS runs the entire length of the medulla oblongata, and the NTS (as well as the trigeminal nucleus) receives somatic sensory input from all cranial nerves, with much of its input coming from the vagus nerve.
  • [0033]
    Convincing evidence has been given that a significant number of neurons in the trigeminal nerve project to the NTS. By applying horseradish peroxidase to peripheral branches of the trigeminal nerve in the cat, it was found that branches of the trigeminal nerve (the lingual and pterygopalatine nerves) were found to contain fibers which ended ipsilaterally in the rostral portions of the NTS, massively in the medial and ventrolateral NTS, moderately in the intermediate and interstitial NTS, and sparsely in the ventral NTS. (The rostral-most part of the NTS was free from labeled terminals.) After injecting the enzyme into the NTS portions rostral to the area postrema, small neurons were scattered in the maxillary and mandibular divisions of the trigeminal ganglion. It was concluded that trigeminal primary afferent neurons project directly to the NTS. By staining for substance P immunoreactivity, it was found that Substance P-containing trigeminal sensory neurons project to the NTS.
  • [0034]
    There is also convincing evidence that a significant number of neurons in the trigeminal nucleus project to the NTS as well. In one study, retrograde transport of a protein-gold complex was used to examine the distribution of spinal cord and trigeminal nucleus caudalis neurons that project to the NTS in the rat. The authors found that retrogradely labeled cells were numerous in the superficial laminae of the trigeminal nucleus caudalis, through its rostrocaudal extent. Since the NTS is an important relay for visceral afferents from both the glossopharyngeal and vagus nerves, it is suggested that the spinal and trigeminal neurons that project to the NTS may be part of a larger system that integrates somatic and visceral afferent inputs from wide areas of the body. The projections may underlie somatovisceral and/or viscerovisceral reflexes, perhaps with a significant afferent nociceptive component.
  • [0035]
    Another study utilized microinfusion and retrograde transport of D-[3H]-aspartate to identify excitatory afferents to the NTS. The authors found that the heaviest labeling was localized bilaterally in the trigeminal nucleus with cells extending through its subdivisions and the entire rostrocaudal axis.
  • [0036]
    In addition, a study by Fanselow, et al. (“Reduction of pentylenetetrazole-induced seizure activity in awake rats by seizure-triggered trigeminal nerve stimulation,” Journal of Neuroscience, 2000 November) demonstrated that unilateral stimulation via a chronically implanted nerve cuff electrode applied to the infraorbital branch of the trigeminal nerve led to a reduction in electrographic seizure activity of up to 78%. The authors reported that bilateral trigeminal stimulation was even more effective.
  • [0037]
    The thalamus is believed to play a major role in some types of epilepsy by acting as a center for seizure onset or as a relay station in allowing a focal seizure to propagate. In a Single Positron Emission Computed Tomography (SPECT) study of patients with left-sided VNS systems, a consistent decrease of activity was found in the left thalamus caused by VNS. The authors concluded that left-sided VNS reduces seizure onset or propagation through inhibition of the thalamic relay center.
  • [0038]
    Thalamic relay neurons are essential in generating 3-Hz absence seizures and are believed to be involved in other types of epilepsy. Thalamic nuclei of some patients suffering from epilepsy display neuronal activities described as “low-threshold calcium spike bursts”, which have been shown to be related to a state of membrane hyperpolarization of thalamic relay neurons. This thalamic rhythmicity is transmitted to the related cortex, thanks to thalamocortical resonant properties. In the cortex, an asymmetrical corticocortical inhibition (edge effect) at the junction between low and high frequency zones is proposed to be at the origin of a cortical activation of high frequency areas bordering low frequency ones.
  • [0039]
    The “thalamic relay” theory has led researchers recently to begin implanting deep brain stimulation (DBS) systems for stimulation of either the centromedian nucleus or the anterior nucleus of the thalamus, in order to treat medically refractory epilepsy patients. Unfortunately, the efficacy of this invasive procedure has thus far proven to be approximately the same as VNS.
  • [0040]
    Drawbacks of VNS and DBS, such as size (of internal and/or external components), discomfort, inconvenience, and/or complex, risky, and expensive surgical procedures, has generally confined their use to patients with severe symptoms and the capacity to finance the surgery. Recently, an alternative to bulky implantable stimulation assemblies has been introduced. Small, implantable microstimulators can be injected into soft tissues through a cannula or needle. See, e.g., U.S. Pat. Nos. 5,324,316 and 5,405,367, both of which patents are incorporated herein by reference. Discussed herein are ways to effectively use such small, fully implantable, chronic neurostimulators for the purpose of treating epilepsy.
  • [0041]
    [0041]FIGS. 1A and 1B depict the trigeminal nerve and its branches. The trigeminal nerve 100 on each side of the head arises from a trigeminal ganglion 102, which lies within the skull in an area known as Meckel's cave 110. In accordance with the teachings of the present invention, access to a trigeminal ganglion may be gained via the foramen ovale 112 or the foramen rotundum 114 in order to implant a miniature neurostimulator adjacent to one or both of the trigeminal ganglia 102.
  • [0042]
    Procedures that ablate the trigeminal ganglia 102 do not disable the muscles of mastication, since the cell bodies of the sensory portion of the nerve are within the trigeminal ganglion, whereas the motor portion simply projects axons through the ganglia (the motor neuron cell bodies are in the pons). This may provide a mechanism for selective stimulation of the sensory cells via appropriate placement of a microstimulator for stimulation of one or both trigeminal ganglia 102.
  • [0043]
    A miniature neurostimulator may additionally or alternatively be implanted adjacent to a trigeminal nerve 100 or any of its branches distal to one or both trigeminal ganglia 102, such as the ophthalmic nerve 120, the maxillary nerve 122, the mandibular nerve 124, and/or branch(es) of any of these. The ophthalmic nerve 120 and the maxillary nerve 122 are entirely sensory, and sufficiently separate to allow independent and selective stimulation via appropriate placement of a microstimulator.
  • [0044]
    The mandibular nerve 124 is both sensory and motor. The mandibular nerve 124 innervates several facial muscles, including the muscles of mastication and the tensor tympani, which reflexively damps down the vibrations of the malleus by making the tympanic membrane more tense. However, just distal to the foramen ovale 112, the mandibular nerve 124 splits into a purely sensory branch that innervates the superior part of the lower jaw. And slightly more distally, another branch splits into a purely sensory branch that innervates the inferior part of the lower jaw. These branches may be sufficiently separate to allow independent and selective stimulation via appropriate placement of a microstimulator.
  • [0045]
    Epilepsy may also be relieved with stimulation additionally or alternatively applied to the greater occipital nerve 130, the lesser occipital nerve 132, and/or the third occipital nerve 134, as well as the facial nerve(s) 136, glossopharyngeal nerve(s) 138, and/or branches of any of these (see FIGS. 2A and 2B). As seen in FIG. 2B, the occipital nerves are relatively easily accessed, especially in their distal portions, since they lie subcutaneously in the back of the head and upper neck.
  • [0046]
    In accordance with the teachings of the present invention, electrical stimulation at one or more of the above-mentioned and/or other trigeminal nerve branches is provided to relieve epilepsy. A microstimulator may be relatively easily implanted via injection and/or via endoscopic means adjacent to one or more of the above-identified nerves or nerve structures. A more complicated surgical procedure may be required for sufficient access to one or more of these nerve structures and/or for fixing the neurostimulator in place. The sites of injection or skin incision could be selected such that the scars would likely be covered by hair in most people.
  • [0047]
    As mentioned above, vagus nerve stimulation (VNS) has demonstrated limited efficacy in the treatment of patients with medically refractory epilepsy. As stated, the mechanism of action of VNS has not been confirmed, but a number researchers believe that VNS may exert its seizure reduction effects through afferent stimulation of the nucleus of tractus solitarius (NTS).
  • [0048]
    As detailed above, studies have shown that the trigeminal nerve also contributes a significant number of afferent fibers to the NTS. Additionally, trigeminal nerve afferents synapse on the trigeminal nucleus in the brainstem, and afferents from the trigeminal nucleus also project to the NTS. Thus, electrical stimulation of, for example, a trigeminal ganglion, trigeminal nerve, or branch(es) of the trigeminal nerve may reasonably be expected to demonstrate efficacy in the treatment of patients with medically refractory epilepsy.
  • [0049]
    Advantageously, stimulation of the trigeminal nerve does not pose the cardiac or vocal cord risks that are associated with VNS. The trigeminal nerve provides sensory innervation to the face, so stimulation may produce a tingling sensation. However, this feeling has not been reported to be unpleasant in patients undergoing sensory nerve stimulation, and in time, patients grow accustomed to the sensation. The trigeminal nerve also innervates the muscles of mastication, so excessive stimulation of these branches may cause fatigue or even spasm of the mandible (i.e., lockjaw). Stimulation of branches that are distal to the motor fibers of the trigeminal nerve should allow these potential motor side effects to be avoided altogether.
  • [0050]
    The present invention is directed to treating epilepsy using one or more small, implantable neurostimulators, referred to herein as “microstimulators”. The microstimulators of the present invention are preferably similar to or of the type referred to as BION™ devices. The following documents describe various features and details associated with the manufacture, operation and use of BION implantable microstimulators, and are all incorporated herein by reference:
    Application/Patent/ Filing/Publication
    Publication No. Date Title
    U.S. Pat. No. 5,193,539 Issued Implantable Microstimulator
    Mar. 16, 1993
    U.S. Pat. No. 5,193,540 Issued Structure and Method of Manufacture of an Implantable
    Mar. 16, 1993 Microstimulator
    U.S. Pat. No. 5,312,439 Issued Implantable Device Having an Electrolytic Storage Electrode
    May 17, 1994
    U.S. Pat. No. 5,324,316 Issued Implantable Microstimulator
    Jun. 28, 1994
    U.S. Pat. No. 5,405,367 Issued Structure and Method of Manufacture of an Implantable
    Apr. 11, 1995 Microstimulator
    U.S. Pat. No. 6,051,017 Issued Improved Implantable Microstimulator and Systems Employing
    Apr. 18, 2000 Same
    PCT Publication published Battery-Powered Patient Implantable Device
    WO 98/37926 Sep. 3, 1998
    PCT Publication published System of Implantable Devices For Monitoring and/or Affecting
    WO 98/43700 Oct. 8, 1998 Body Parameters
    PCT Publication published System of Implantable Devices For Monitoring and/or Affecting
    WO 98/43701 Oct. 8, 1998 Body Parameters
    published Micromodular Implants to Provide Electrical Stimulation of
    September, 1997 Paralyzed Muscles and Limbs, by Cameron, et al., published in
    IEEE Transactions on Biomedical Engineering, Vol. 44, No. 9,
    pages 781-790.
  • [0051]
    As shown in FIG. 3, microstimulator device 150 includes a narrow, elongated capsule 152 containing electronic circuitry 154 connected to electrodes 156 and 158, which may pass through the walls of the capsule at either end. As detailed in the referenced patent publications, electrodes 156 and 158 generally comprise a stimulating electrode (to be placed close to the nerve) and an indifferent electrode (for completing the circuit). Other configurations of microstimulator device 150 are possible, as is evident from the above-referenced patent publications, and as described in more detail herein.
  • [0052]
    Certain configurations of implantable microstimulator 150 are sufficiently small to permit its placement adjacent to the structures to be stimulated. (As used herein, “adjacent” and “near” mean as close as reasonably possible to targeted tissue, including touching or even being positioned within the tissue, but in general, may be as far as about 150 mm from the target tissue. A single microstimulator 150 may be implanted, or two or more microstimulators may be implanted to achieve greater stimulation of the targeted tissue, or for a longer period of time.
  • [0053]
    Capsule 152 of FIG. 3 may have a diameter of about 4-5 mm, or only about 3 mm, or even less than about 3 mm. Capsule 152 length may be about 25-35 mm, or only about 20-25 mm, or even less than about 20 mm. The shape of the microstimulator may be determined by the structure of the desired target, the surrounding area, and the method of implantation. A thin, elongated cylinder with electrodes at the ends, as shown in FIG. 3, is one possible configuration, but other shapes, such as spheres, disks, or helical structures, are possible, as are additional electrodes.
  • [0054]
    Microstimulator 150 may be implanted with a surgical insertion tool specially designed for the purpose, or may be injected (e.g., via a hypodermic needle). Alternatively, device 150 may be implanted via conventional surgical methods, or may be inserted using other endoscopic or laparoscopic techniques. A more complicated surgical procedure may be required for fixing the neurostimulator in place.
  • [0055]
    The external surfaces of stimulator 150 may advantageously be composed of biocompatible materials. Capsule 152 may be made of, for instance, glass, ceramic, or other material that provides a hermetic package that will exclude water vapor but permit passage of electromagnetic fields used to transmit data and/or power. Electrodes 156 and 158 may be made of a noble or refractory metal or compound, such as platinum, iridium, tantalum, titanium, titanium nitride, niobium, or alloys of any of these, in order to avoid corrosion or electrolysis which could damage the surrounding tissues and the device.
  • [0056]
    In certain embodiments of the instant invention, microstimulator 150 comprises two, leadless electrodes. However, either or both electrodes 156 and 158 may alternatively be located at the ends of short, flexible leads as described in U.S. patent application Ser. No. 09/624,130, filed Jul. 24, 2000, which is incorporated herein by reference in its entirety. The use of such leads permits, among other things, electrical stimulation to be directed more locally to targeted tissue(s) a short distance from the surgical fixation of the bulk of the implantable stimulator 150, while allowing most elements of stimulator 150 to be located in a more surgically convenient site. This minimizes the distance traversed and the surgical planes crossed by the device and any lead(s). In most uses of this invention, the leads are no longer than about 150 mm.
  • [0057]
    Microstimulator 150 contains, when necessary and/or desired, electronic circuitry 154 for receiving data and/or power from outside the body by inductive, radio-frequency (RF), or other electromagnetic coupling. In some embodiments, electronic circuitry 154 includes an inductive coil for receiving and transmitting RF data and/or power, an integrated circuit (IC) chip for decoding and storing stimulation parameters and generating stimulation pulses (either intermittent or continuous), and additional discrete electronic components required to complete the electronic circuit functions, e.g. capacitor(s), resistor(s), coil(s), and the like.
  • [0058]
    Neurostimulator 150 includes, when necessary and/or desired, a programmable memory 160 for storing a set(s) of data, stimulation, and control parameters. Among other things, memory 160 may allow stimulation and control parameters to be adjusted to settings that are safe and efficacious with minimal discomfort for each individual. Specific parameters may provide therapeutic advantages for various forms of epilepsy. For instance, some patients may respond favorably to intermittent stimulation, while others may require continuous stimulation to alleviate their symptoms.
  • [0059]
    In addition, stimulation parameters may be chosen to target specific neural populations and to exclude others, or to increase neural activity in specific neural populations and to decrease neural activity in others. For example, relatively low frequency neurostimulation (i.e., less than about 100-150 Hz) typically has an excitatory effect on surrounding neural tissue, leading to increased neural activity, whereas relatively high frequency neurostimulation (i.e., greater than about 100-150 Hz) may have an inhibitory effect, leading to decreased neural activity.
  • [0060]
    Some embodiments of implantable stimulator 150 also includes a power source and/or power storage device 162. Possible power options for a stimulation device of the present invention, described in more detail below, include but are not limited to an external power source coupled to stimulator 150, e.g., via an RF link, a self-contained power source utilizing any suitable means of generation or storage of energy (e.g., a primary battery, a replenishable or rechargeable battery such as a lithium ion battery, an electrolytic capacitor, a super- or ultra-capacitor, or the like), and if the self-contained power source is replenishable or rechargeable, means of replenishing or recharging the power source (e.g., an RF link, an optical link, a thermal link, or other energy-coupling link).
  • [0061]
    According to certain embodiments of the invention, a microstimulator operates independently. According to various embodiments of the invention, a microstimulator operates in a coordinated manner with other microstimulator(s), other implanted device(s), or other device(s) external to the patient's body. For instance, a microstimulator may control or operate under the control of another implanted microstimulator(s), other implanted device(s), or other device(s) external to the patient's body. A microstimulator may communicate with other implanted microstimulators, other implanted devices, and/or devices external to a patient's body via, e.g., an RF link, an ultrasonic link, a thermal link, an optical link, or the like. Specifically, a microstimulator may communicate with an external remote control (e.g., patient and/or physician programmer) that is capable of sending commands and/or data to a microstimulator and that may also be capable of receiving commands and/or data from a microstimulator.
  • [0062]
    In certain embodiments, and as illustrated in FIG. 4, the patient 170 switches the implantable stimulator 150 on and off by use of controller 180, which may be handheld. Implantable stimulator 150 is operated by controller 180 by any of various means, including sensing the proximity of a permanent magnet located in controller 180, sensing RF transmissions from controller 180, or the like.
  • [0063]
    External components for programming and/or providing power to various embodiments of implantable stimulator 150 are also illustrated in FIG. 4. When communication with the implanted stimulator 150 is desired, patient 170 is positioned on or near external appliance 190, which appliance contains one or more inductive coils 192 or other means of communication (e.g., RF transmitter and receiver). External appliance 190 is connected to or is a part of external electronic circuitry appliance 200 which may receive power 202 from a conventional power source. External appliance 200 contains manual input means 208, e.g., a keypad, whereby the patient 170 or a caregiver 212 can request changes in the stimulation parameters produced during the normal operation of the implantable stimulator 150. In these embodiments, manual input means 208 includes various electro-mechanical switches and/or visual display devices that provide the patient and/or caregiver with information about the status and prior programming of the implantable stimulator 150.
  • [0064]
    Alternatively or additionally, external electronic appliance 200 is provided with an electronic interface means 216 for interacting with other computing means 218, such as by a serial interface cable or infrared link to a personal computer or to a telephone modem or the like. Such interface means 216 may permit a clinician to monitor the status of the implant and prescribe new stimulation parameters from a remote location.
  • [0065]
    The external appliance(s) may be embedded in a cushion, pillow, hat, or garment. Other possibilities exist, including a headband, patch or other structure(s) that may be affixed to the patient's body or clothing. External appliances may include a package that can be, e.g., worn on the belt, may include an extension to a transmission coil affixed, e.g., with a velcro band or adhesive, or may be combinations of these or other structures able to perform the functions described herein.
  • [0066]
    In order to help determine the strength and/or duration of electrical stimulation required to produce the desired effect, in some embodiments, a patient's response to and/or need for treatment is sensed. For example, electrical activity of the brain (e.g., EEG), electrical activity of a nerve (e.g., ENG), muscle activity (e.g., EMG), and/or abnormal movements resulting from a seizure (e.g., accelerometer activity) may be sensed. Other measures of the state of the patient may additionally or alternatively be sensed. For instance, medication, neurotransmitter, hormone, cytokine, and/or enzyme levels or their changes, and/or levels or changes in other substance(s) borne in the blood and/or in the cerebrospinal fluid (CSF) may be sensed, using, e.g., one or more Chemically Sensitive Field-Effect Transistors (CHEMFETs) such as Enzyme-Selective Field-Effect Transistors (ENFETs) or Ion-Sensitive Field-Effect Transistors (ISFETs, as are available from Sentron CMT of Enschede, The Netherlands). For instance, the level or changes in level of neuron-specific enolase, a key glycolytic enzyme, in either or both the blood serum or CSF may be sensed.
  • [0067]
    For example, when electrodes of implantable stimulator 150 are implanted adjacent to a trigeminal nerve branch, a sensor or stimulating electrode (or other electrode) of microstimulator 150 may be used to sense changes in EEG resulting from the stimulation applied to the nerve. Alternatively, a “microstimulator” dedicated to sensory processes communicates with a microstimulator that provides the stimulation pulses. The implant circuitry 154 may, if necessary, amplify and transmit these sensed signals, which may be analog or digital. Other methods of determining the required stimulation include a sensor implanted in the brain in an area where altered activity correlates with possible seizures (e.g., the seizure focus and/or near thalamic relay neurons), as well as other methods mentioned herein, and yet others that will be evident to those of skill in the art upon review of the present disclosure. The sensed information may be used to control stimulation parameters in a closed-loop manner.
  • [0068]
    For instance, in several embodiments of the present invention, a first and second “stimulator” are provided. The second “stimulator” periodically (e.g. once per minute) records a level of brain activity (or accelerometer activity, etc.), which it transmits to the first stimulator. The first stimulator uses the sensed information to adjust stimulation parameters according to an algorithm programmed, e.g., by a physician. For example, the amplitude of stimulation may be increased in response to increased activity in brain areas which demonstrate increased activity during epileptic attacks. In some alternatives, one stimulator performs both the sensing and stimulating functions, as discussed in more detail presently.
  • [0069]
    While a microstimulator may also incorporate means of sensing epileptic seizures, it may alternatively or additionally be desirable to use a separate or specialized implantable device to record and telemeter physiological conditions/responses in order to adjust stimulation parameters. This information may be transmitted to an external device, such as external appliance 190, or may be transmitted directly to implanted stimulator(s) 150. However, in some cases, it may not be necessary or desired to include a sensing function or device, in which case stimulation parameters are determined and refined, for instance, by patient feedback, or the like.
  • [0070]
    Thus, it is seen that in accordance with the present invention, one or more external appliances may be provided to interact with microstimulator 150, and may be used to accomplish, potentially among other things, one or more of the following functions:
  • [0071]
    Function 1: If necessary, transmit electrical power from the external electronic appliance 200 via appliance 190 to the implantable stimulator 150 in order to power the device and/or recharge the power source/storage device 162. External electronic appliance 200 may include an automatic algorithm that adjusts stimulation parameters automatically whenever the implantable stimulator(s) 150 is/are recharged.
  • [0072]
    Function 2: Transmit data from the external appliance 200 via the external appliance 190 to the implantable stimulator 150 in order to change the operational parameters (e.g., electrical stimulation parameters) used by stimulator 150.
  • [0073]
    Function 3: Transmit sensed data indicating a need for treatment or in response to stimulation from neurostimulator 150 (e.g., EEG, change in neurotransmitter or medication level, or other activity) to external appliance 200 via external appliance 190.
  • [0074]
    Function 4: Transmit data indicating state of the implantable stimulator 150 (e.g., battery level, stimulation settings, etc.) to external appliance 200 via external appliance 190.
  • [0075]
    By way of example, a treatment modality for epilepsy may be carried out according to the following sequence of procedures:
  • [0076]
    1. A stimulator 150 is implanted so that its electrodes 156 and 158 are adjacent to a branch of trigeminal nerve 100. If necessary or desired, one or more additional stimulator(s) 150 may additionally or alternatively be implanted adjacent to other nerve structures, such as a trigeminal ganglion 102, ophthalmic nerve 120, maxillary nerve 122, mandibular nerve 124, greater occipital nerve 130, lesser occipital nerve 132, third occipital nerve 134, facial nerve 136, glossopharyngeal nerve 138, and/or branches of any of these nerves.
  • [0077]
    2. Using Function 2 described above (i.e., transmitting data) of external electronic appliance 200 and external appliance 190, implantable stimulator 150 is commanded to produce a series of electrical stimulation pulses with gradually increasing amplitude.
  • [0078]
    3. After each stimulation pulse, series of pulses, or at some other predefined interval, any change in, e.g., EEG and/or neurotransmitter and/or medication level is sensed, for instance, by one or more electrodes 156 and 158 or sensors (e.g., a CHEMFET). These responses are converted to data and telemetered out to external electronic appliance 200 via Function 3.
  • [0079]
    4. From the response data received at external appliance 200 from the implantable stimulator 150, or from other assessment, the stimulus threshold for obtaining a response is determined and is used by a clinician acting directly 212 or by other computing means 218 to transmit the desired stimulation parameters to the implantable stimulator 150 in accordance with Function 2.
  • [0080]
    5. When patient 170 desires to invoke electrical stimulation to alleviate symptoms, patient 170 employs controller 180 to set the implantable stimulator 150 in a state where it delivers a prescribed stimulation pattern from a predetermined range of allowable stimulation patterns.
  • [0081]
    6. To cease electrical stimulation, patient 170 employs controller 180 to turn off stimulator 150.
  • [0082]
    7. Periodically, the patient or caregiver recharges the power source/storage device 162 of implantable stimulator 150, if necessary, in accordance with Function 1 described above (i.e., transmit electrical power).
  • [0083]
    For the treatment of any of the various types and degrees of epilepsy, it may be desirable to modify or adjust the algorithmic functions performed by the implanted and/or external components, as well as the surgical approaches, in ways that would be obvious to skilled practitioners of these arts. For example, in some situations, it may be desirable to employ more than one implantable stimulator 150, each of which could be separately controlled by means of a digital address. Multiple channels and/or multiple patterns of stimulation might thereby be programmed by the clinician and controlled by the patient in order to, for instance, stimulate larger areas of neural tissue in order to maximize therapeutic efficacy.
  • [0084]
    In some embodiments discussed earlier, microstimulator 150, or a group of two or more microstimulators, is controlled via closed-loop operation. A need for and/or response to stimulation is sensed via microstimulator 150, or by an additional microstimulator (which may or may not be dedicated to the sensing function), or by another implanted or external device. If necessary, the sensed information is transmitted to microstimulator 150. In some embodiments, the stimulation parameters used by microstimulator 150 are automatically adjusted based on the sensed information. Thus, the stimulation parameters are adjusted in a closed-loop manner to provide stimulation tailored to the need for and/or response to stimulation.
  • [0085]
    For instance, in some embodiments of the present invention, a first and second “stimulator” are provided. The second “stimulator” periodically (e.g. once per minute) records e.g., EEG, neurotransmitter level, and/or medication level, which it transmits to the first stimulator. The first stimulator uses the sensed information to adjust stimulation parameters according to an algorithm programmed, e.g., by a clinician. For example, stimulation amplitude may be activated or increased in response to increased seizure activity on EEG, e.g., increased number of spikes per minute recorded on EEG. Alternatively, one “microstimulator” performs both the sensing and stimulating functions.
  • [0086]
    For example, as shown in the example of FIG. 5, a first microstimulator 150, implanted beneath the skin of patient 170, provides electrical stimulation via electrodes 156 and 158 to a first location; a second microstimulator 150′ provides electrical stimulation to a second location; and a third microstimulator 150″ provides electrical stimulation to a third location. As mentioned earlier, the implanted devices may operate independently or may operate in a coordinated manner with other similar implanted devices, other implanted devices, or other devices external to the patient's body, as shown by the control lines 222, 223 and 224 in FIG. 5. That is, in accordance with certain embodiments of the invention, external controller 220 controls the operation of each of the implanted microstimulators 150, 150′ and 150″. According to various embodiments of the invention, an implanted device, e.g. microstimulator 150, may control or operate under the control of another implanted device(s), e.g., microstimulator 150′ and/or microstimulator 150″. That is, a device made in accordance with the invention may communicate with other implanted stimulators, other implanted devices, and/or devices external to a patient's body, e.g., via an RF link, an ultrasonic link, a thermal link, an optical link, or other communications link. Specifically, as illustrated in FIG. 5, microstimulator 150, 150′, and/or 150″, made in accordance with the invention, may communicate with an external remote control (e.g., patient and/or physician programmer 220) that is capable of sending commands and/or data to implanted devices and that may also be capable of receiving commands and/or data from implanted devices.
  • [0087]
    A microstimulator made in accordance with the invention may incorporate, in some embodiments, first sensing means 228 for sensing therapeutic effects, clinical variables, or other indicators of the state of the patient, such as EEG, ENG, EMG, abnormal movements, and/or other marker of the potential for seizure. The stimulator additionally or alternatively incorporates second means 229 for sensing levels or changes in one or more medications, neurotransmitters, hormones, cytokines, enzymes, and/or other substances in the blood plasma, in the cerebrospinal fluid, or in the local interstitial fluid. The stimulator additionally or alternatively incorporates third means 230 for sensing electrical current levels and/or waveforms supplied by another source of electrical energy. Sensed information may be used to control the parameters of the stimulator(s) in a closed loop manner, as shown by control lines 225, 226, and 227. Thus, the sensing means may be incorporated into a device that also includes electrical stimulation means, or the sensing means (that may or may not have stimulating means) may communicate the sensed information to another device(s) with stimulating means.
  • [0088]
    While a microstimulator may also incorporate means of sensing the condition of a patient, e.g., via EEG, ENG, EMG, or accelerometer activity, it may alternatively or additionally be desirable to use a separate or specialized implantable device to sense and telemeter physiological conditions/responses in order to adjust stimulation parameters. This information may be transmitted to an external device, such as external appliance 220, or may be transmitted directly to implanted stimulator(s) 150. However, in some cases, it may not be necessary or desired to include a sensing function or device, in which case stimulation parameters may be determined and refined, for instance, by patient feedback.
  • [0089]
    Again, microstimulator(s) 150 may be implanted adjacent to one or more of a trigeminal nerve 100, trigeminal ganglion 102, ophthalmic nerve 120, maxillary nerve 122, mandibular nerve 124, greater occipital nerve 130, lesser occipital nerve 132, third occipital nerve 134, facial nerve 136, glossopharyngeal nerve 138, and/or one or more nerve branches of any of these. According to several embodiments of the invention, symptoms of epilepsy are alleviated by decreasing excitement of these nerve fibers. As indicated above, inhibition of the NTS leads to a decrease in epileptic symptoms in certain types of epilepsy. Relatively high-frequency electrical stimulation (e.g., greater than about 100-150 Hz) is likely to produce such inhibition.
  • [0090]
    According to various embodiments of the invention, symptoms of certain other types of epilepsy are alleviated by alternatively increasing excitement of certain of these nerve fibers. Relatively low-frequency electrical stimulation (e.g., less than about 100-150 Hz) is likely to produce such excitement.
  • [0091]
    Additionally, sensing means described earlier may be used to orchestrate first the activation of microstimulator(s) targeting one or more nerves in one area, and then, when appropriate, the microstimulator(s) targeting nerves in the same or another area, in order to control symptoms, for instance, by a different means. Alternatively, this orchestration may be programmed, and not based on a sensed condition.
  • [0092]
    While the invention herein disclosed has been described by means of specific embodiments and applications thereof, numerous modifications and variations could be made thereto by those skilled in the art without departing from the scope of the invention set forth in the claims.

Claims (23)

    What is claimed is:
  1. 1. A method for treating a patient with epilepsy, comprising:
    providing at least one leadless stimulator having at least two electrodes;
    implanting the at least one stimulator adjacent to at least one nerve structure at least in part responsible for epileptic seizures;
    providing operating power to the at least one stimulator;
    using at least one external appliance to transmit stimulation parameters to the at least one stimulator;
    receiving and storing the stimulation parameters;
    generating stimulation pulses in accordance with the stimulation parameters; and
    delivering the stimulation pulses to nerves adjacent to the at least one stimulator;
    wherein the stimulator has a size and shape suitable for placement of the electrodes adjacent to the at least one nerve structure.
  2. 2. The method of claim 1 wherein the at least one nerve structure comprises at least one of a trigeminal nerve, a branch of the trigeminal nerve, a trigeminal ganglion, an ophthalmic nerve, a branch of the ophthalmic nerve, a maxillary nerve, a branch of the maxillary nerve, a mandibular nerve, a branch of the mandibular nerve, a greater occipital nerve, a branch of the greater occipital nerve, a lesser occipital nerve, a branch of the lesser occipital nerve, a third occipital nerve, a branch of the third occipital nerve, a facial nerve, a branch of the facial nerve, a glossopharyngeal nerve, and a branch of the glossopharyngeal nerve.
  3. 3. The method of claim 2 wherein the stimulation pulses are delivered at greater than about 100 to 150 Hz.
  4. 4. The method of claim 2 wherein the stimulation pulses are delivered at less than about 100 to 150 Hz.
  5. 5. The method of claim 1 further comprising
    providing at least one sensor;
    using the at least one sensor to sense a physical condition; and
    determining the stimulation parameters based upon the sensed condition.
  6. 6. The method of claim 5 wherein the at least one sensor is a part of the stimulator.
  7. 7. The method of claim 1 further comprising providing and implanting more than one stimulator.
  8. 8. A method for treating a patient with epilepsy, comprising the steps of:
    providing at least one means for stimulating tissue;
    implanting the at least one stimulating means adjacent to at least one nerve structure at least in part responsible for epileptic seizures;
    providing operating power to the at least one stimulating means;
    transmitting stimulation parameters to the at least one stimulating means using at least one external appliance;
    receiving and storing the stimulation parameters;
    generating stimulation pulses in accordance with the stimulation parameters; and
    delivering the stimulation pulses to nerves structures adjacent to the at least one stimulating means;
    wherein the stimulating means has a size and shape suitable for placement near the at least one nerve and has leads up to 150 mm long.
  9. 9. The method of claim 8 wherein the body of the stimulator is no more than 150 mm from the at least one nerve structure to be stimulated.
  10. 10. The method of claim 9 wherein the at least one nerve structure comprises at least one of a trigeminal nerve, a branch of the trigeminal nerve, a trigeminal ganglion, an ophthalmic nerve, a branch of the ophthalmic nerve, a maxillary nerve, a branch of the maxillary nerve, a mandibular nerve, a branch of the mandibular nerve, a greater occipital nerve, a branch of the greater occipital nerve, a lesser occipital nerve, a branch of the lesser occipital nerve, a third occipital nerve, a branch of the third occipital nerve, a facial nerve, a branch of the facial nerve, a glossopharyngeal nerve, and a branch of the glossopharyngeal nerve.
  11. 11. A method for treating a patient with epilepsy, comprising:
    providing at least one leadless stimulator having at least two electrodes;
    providing at least one sensor;
    implanting the at least one stimulator adjacent to at least one nerve structure at least in part responsible for epileptic seizures;
    providing operating power to the at least one stimulator;
    using the sensor to sense a physical condition;
    determining stimulation parameters based upon the sensed condition;
    generating stimulation pulses in accordance with the stimulation parameters; and
    delivering the stimulation pulses to nerves structures adjacent to the at least two electrodes;
    wherein the stimulator has a size and shape suitable for placement of the electrodes adjacent to the at least one nerve structure.
  12. 12. The method of claim 11 wherein the at least one sensor is a part of the stimulator.
  13. 13. The method of claim 11 wherein the stimulation parameters are determined using at least one external appliance.
  14. 14. The method of claim 11 wherein providing power to the at least one stimulator comprises receiving power from at least one external appliance.
  15. 15. The method of claim 14 wherein providing power to the at least one stimulator further comprises storing the power received from the at least one external appliance.
  16. 16. The method of claim 11 further comprising providing and implanting more than one stimulator.
  17. 17. The method of claim 11 wherein the at least one nerve structure comprises at least one of a trigeminal nerve, a branch of the trigeminal nerve, a trigeminal ganglion, an ophthalmic nerve, a branch of the ophthalmic nerve, a maxillary nerve, a branch of the maxillary nerve, a mandibular nerve, a branch of the mandibular nerve, a greater occipital nerve, a branch of the greater occipital nerve, a lesser occipital nerve, a branch of the lesser occipital nerve, a third occipital nerve, a branch of the third occipital nerve, a facial nerve, a branch of the facial nerve, a glossopharyngeal nerve, and a branch of the glossopharyngeal nerve.
  18. 18. The method of claim 11 wherein the sensor senses at least one of electrical activity of the brain, electrical activity of a nerve, muscle activity, and patient movement.
  19. 19. The method of claim 11 wherein the sensor senses at least one of medication level, neurotransmitter level, hormone level, cytokine level, enzyme level, level of a bloodborne substance, and level of a substance in the cerebrospinal fluid.
  20. 20. A system for treating a patient with epilepsy, comprising:
    at least one leadless stimulator having at least two electrodes;
    means for implanting the at least one stimulator adjacent to at least one nerve structure at least in part responsible for epileptic seizures;
    means for providing operating power to the at least one stimulator;
    at least one external appliance used to transmit stimulation parameters to the at least one stimulator;
    means for receiving and storing the stimulation parameters; and
    means for generating stimulation pulses in accordance with the stimulation parameters;
    wherein the at least two electrodes deliver the stimulation pulses to nerves adjacent to the at least one stimulator; and
    wherein the stimulator has a size and shape suitable for placement of the electrodes adjacent to the at least one nerve structure.
  21. 21. The system of claim 20 further comprising
    at least one sensor for sensing a physical condition; and
    means for determining the stimulation parameters based upon the sensed condition.
  22. 22. The system of claim 21 wherein the sensor includes means for sensing at least one of electrical activity of the brain, electrical activity of a nerve, muscle activity, and patient movement.
  23. 23. The system of claim 21 wherein the sensor includes means for sensing at least one of medication level, neurotransmitter level, hormone level, cytokine level, enzyme level, level of a bloodborne substance, and level of a substance in the cerebrospinal fluid.
US10057115 2001-01-30 2002-01-24 Fully implantable miniature neurostimulator for stimulation as a therapy for epilepsy Active 2022-09-23 US6788975B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US26500801 true 2001-01-30 2001-01-30
US10057115 US6788975B1 (en) 2001-01-30 2002-01-24 Fully implantable miniature neurostimulator for stimulation as a therapy for epilepsy

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10057115 US6788975B1 (en) 2001-01-30 2002-01-24 Fully implantable miniature neurostimulator for stimulation as a therapy for epilepsy
US11073078 US7493172B2 (en) 2001-01-30 2005-03-04 Methods and systems for stimulating a nerve originating in an upper cervical spine area to treat a medical condition
US11246807 US20060064140A1 (en) 2001-01-30 2005-10-07 Methods and systems for stimulating a trigeminal nerve to treat a psychiatric disorder

Publications (2)

Publication Number Publication Date
US20040172089A1 true true US20040172089A1 (en) 2004-09-02
US6788975B1 US6788975B1 (en) 2004-09-07

Family

ID=32911611

Family Applications (1)

Application Number Title Priority Date Filing Date
US10057115 Active 2022-09-23 US6788975B1 (en) 2001-01-30 2002-01-24 Fully implantable miniature neurostimulator for stimulation as a therapy for epilepsy

Country Status (1)

Country Link
US (1) US6788975B1 (en)

Cited By (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030083698A1 (en) * 2001-11-01 2003-05-01 Whitehurst Todd K. Thrombolysis and chronic anticoagulation therapy
US20030236557A1 (en) * 2002-06-20 2003-12-25 Whitehurst Todd K. Cavernous nerve stimulation via unidirectional propagation of action potentials
US20030236558A1 (en) * 2002-06-20 2003-12-25 Whitehurst Todd K. Vagus nerve stimulation via unidirectional propagation of action potentials
US20040015205A1 (en) * 2002-06-20 2004-01-22 Whitehurst Todd K. Implantable microstimulators with programmable multielectrode configuration and uses thereof
US20040015204A1 (en) * 2002-06-20 2004-01-22 Whitehurst Todd K. Implantable microstimulators and methods for unidirectional propagation of action potentials
US20040254618A1 (en) * 2000-03-13 2004-12-16 Schroeppel Edward A. Implantable device and method for the electrical treatment of cancer
US20050004507A1 (en) * 2000-03-13 2005-01-06 Oncostim. Inc. Method and device for treating cancer with electrical therapy in conjunction with chemotherapeutic agents and radiation therapy
US20050209652A1 (en) * 2001-04-26 2005-09-22 Whitehurst Todd K Methods and systems for electrical and/or drug stimulation as a therapy for erectile dysfunction
US20050222623A1 (en) * 2004-04-06 2005-10-06 Oncostim Inc., A Minnesota Corporation Partially implantable system for the electrical treatment of cancer
US20050222646A1 (en) * 2004-04-06 2005-10-06 Kai Kroll Method and device for treating cancer with modified output electrical therapy
US20060052836A1 (en) * 2004-09-08 2006-03-09 Kim Daniel H Neurostimulation system
US20060149337A1 (en) * 2005-01-21 2006-07-06 John Michael S Systems and methods for tissue stimulation in medical treatment
US20060206162A1 (en) * 2005-03-11 2006-09-14 Wahlstrand Carl D Implantable neurostimulator device
US20060206163A1 (en) * 2005-03-11 2006-09-14 Wahlstrand Carl D Neurostimulation site screening
US20060229688A1 (en) * 2005-04-08 2006-10-12 Mcclure Kelly H Controlling stimulation parameters of implanted tissue stimulators
US20070016263A1 (en) * 2005-07-13 2007-01-18 Cyberonics, Inc. Neurostimulator with reduced size
US20070027499A1 (en) * 2005-07-29 2007-02-01 Cyberonics, Inc. Neurostimulation device for treating mood disorders
US20070027500A1 (en) * 2005-07-29 2007-02-01 Cyberonics, Inc. Selective neurostimulation for treating mood disorders
US20070060954A1 (en) * 2005-02-25 2007-03-15 Tracy Cameron Method of using spinal cord stimulation to treat neurological disorders or conditions
US20070142874A1 (en) * 2005-01-21 2007-06-21 John Michael S Multiple-symptom medical treatment with roving-based neurostimulation.
US20080033502A1 (en) * 2006-06-23 2008-02-07 Neurovista Corporation A Delaware Corporation Minimally Invasive System for Selecting Patient-Specific Therapy Parameters
US20090024075A1 (en) * 1999-04-09 2009-01-22 Schroeppel Edward A Method and Device for Treating Abnormal Tissue Growth With Electrical Therapy
US7499752B2 (en) 2005-07-29 2009-03-03 Cyberonics, Inc. Selective nerve stimulation for the treatment of eating disorders
US20090112282A1 (en) * 2007-10-26 2009-04-30 Medtronic, Inc. Occipital nerve stimulation
US7555344B2 (en) 2005-10-28 2009-06-30 Cyberonics, Inc. Selective neurostimulation for treating epilepsy
US20090270943A1 (en) * 2008-04-25 2009-10-29 Maschino Steven E Blocking Exogenous Action Potentials by an Implantable Medical Device
US20100030227A1 (en) * 2008-07-31 2010-02-04 Medtronic, Inc. Medical lead implantation
US20100049188A1 (en) * 2008-08-20 2010-02-25 Ionix Medical, Inc. Non-Thermal Ablation System for Treating Tissue
US20100121215A1 (en) * 2008-11-11 2010-05-13 Medtronic, Inc. Seizure detection algorithm adjustment
US7729758B2 (en) 2005-11-30 2010-06-01 Boston Scientific Neuromodulation Corporation Magnetically coupled microstimulators
US7747325B2 (en) 1998-08-05 2010-06-29 Neurovista Corporation Systems and methods for monitoring a patient's neurological disease state
US7801600B1 (en) 2005-05-26 2010-09-21 Boston Scientific Neuromodulation Corporation Controlling charge flow in the electrical stimulation of tissue
US7801601B2 (en) 2006-01-27 2010-09-21 Cyberonics, Inc. Controlling neuromodulation using stimulus modalities
US7803148B2 (en) 2006-06-09 2010-09-28 Neurosystec Corporation Flow-induced delivery from a drug mass
US20100280336A1 (en) * 2009-04-30 2010-11-04 Medtronic, Inc. Anxiety disorder monitoring
US7853329B2 (en) 1998-08-05 2010-12-14 Neurovista Corporation Monitoring efficacy of neural modulation therapy
US20100331807A1 (en) * 2002-05-24 2010-12-30 Boston Scientific Neuromodulation Corporation Treatment of movement disorders by brain stimulation
US7865243B1 (en) 2000-04-07 2011-01-04 Boston Scientific Neuromodulation Corporation Device and therapy for erectile dysfunction and other sexual dysfunction
US7869867B2 (en) 2006-10-27 2011-01-11 Cyberonics, Inc. Implantable neurostimulator with refractory stimulation
US7869885B2 (en) 2006-04-28 2011-01-11 Cyberonics, Inc Threshold optimization for tissue stimulation therapy
US7869884B2 (en) 2007-04-26 2011-01-11 Cyberonics, Inc. Non-surgical device and methods for trans-esophageal vagus nerve stimulation
US7877136B1 (en) 2007-09-28 2011-01-25 Boston Scientific Neuromodulation Corporation Enhancement of neural signal transmission through damaged neural tissue via hyperpolarizing electrical stimulation current
US7904175B2 (en) 2007-04-26 2011-03-08 Cyberonics, Inc. Trans-esophageal vagus nerve stimulation
US20110077579A1 (en) * 2005-03-24 2011-03-31 Harrison William V Cochlear implant with localized fluid transport
US20110093036A1 (en) * 2009-10-20 2011-04-21 Nyxoah SA Implantable Electrical Stimulator
US20110112592A1 (en) * 2005-04-20 2011-05-12 Imad Libbus Neural stimulation system to prevent simultaneous energy discharges
US7962214B2 (en) 2007-04-26 2011-06-14 Cyberonics, Inc. Non-surgical device and methods for trans-esophageal vagus nerve stimulation
US20110152965A1 (en) * 2009-12-21 2011-06-23 Nyxoah SA Diagnosis and Prediction of Obstructive Sleep Apnea
US7974701B2 (en) 2007-04-27 2011-07-05 Cyberonics, Inc. Dosing limitation for an implantable medical device
US8036736B2 (en) 2007-03-21 2011-10-11 Neuro Vista Corporation Implantable systems and methods for identifying a contra-ictal condition in a subject
US8150508B2 (en) 2006-03-29 2012-04-03 Catholic Healthcare West Vagus nerve stimulation method
US8295934B2 (en) 2006-11-14 2012-10-23 Neurovista Corporation Systems and methods of reducing artifact in neurological stimulation systems
US8380318B2 (en) 2009-03-24 2013-02-19 Spinal Modulation, Inc. Pain management with stimulation subthreshold to paresthesia
JP2013506533A (en) * 2009-10-05 2013-02-28 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Apparatus for the treatment of neuropsychiatric disorders, systems and methods
US20130085541A1 (en) * 2011-09-30 2013-04-04 Adi Mashiach Devices and Methods for Delivering Energy as a Function of Condition Severity
US8457747B2 (en) 2008-10-20 2013-06-04 Cyberonics, Inc. Neurostimulation with signal duration determined by a cardiac cycle
US8565867B2 (en) 2005-01-28 2013-10-22 Cyberonics, Inc. Changeable electrode polarity stimulation by an implantable medical device
US8588933B2 (en) 2009-01-09 2013-11-19 Cyberonics, Inc. Medical lead termination sleeve for implantable medical devices
US8725243B2 (en) 2005-12-28 2014-05-13 Cyberonics, Inc. Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US8762065B2 (en) 1998-08-05 2014-06-24 Cyberonics, Inc. Closed-loop feedback-driven neuromodulation
US8774937B2 (en) 2009-12-01 2014-07-08 Ecole Polytechnique Federale De Lausanne Microfabricated surface neurostimulation device and methods of making and using the same
US8788042B2 (en) 2008-07-30 2014-07-22 Ecole Polytechnique Federale De Lausanne (Epfl) Apparatus and method for optimized stimulation of a neurological target
US8788064B2 (en) 2008-11-12 2014-07-22 Ecole Polytechnique Federale De Lausanne Microfabricated neurostimulation device
US8786624B2 (en) 2009-06-02 2014-07-22 Cyberonics, Inc. Processing for multi-channel signals
US8805494B2 (en) 2005-05-10 2014-08-12 Cardiac Pacemakers, Inc. System and method to deliver therapy in presence of another therapy
US8849390B2 (en) 2008-12-29 2014-09-30 Cyberonics, Inc. Processing for multi-channel signals
US8868172B2 (en) 2005-12-28 2014-10-21 Cyberonics, Inc. Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
US8983624B2 (en) 2006-12-06 2015-03-17 Spinal Modulation, Inc. Delivery devices, systems and methods for stimulating nerve tissue on multiple spinal levels
US9042988B2 (en) 1998-08-05 2015-05-26 Cyberonics, Inc. Closed-loop vagus nerve stimulation
US9044592B2 (en) 2007-01-29 2015-06-02 Spinal Modulation, Inc. Sutureless lead retention features
US9056197B2 (en) 2008-10-27 2015-06-16 Spinal Modulation, Inc. Selective stimulation systems and signal parameters for medical conditions
WO2016014857A1 (en) * 2014-07-23 2016-01-28 Department Of Veterans Affairs Parasympathetic activation by vagus nerve stimulation
US9259591B2 (en) 2007-12-28 2016-02-16 Cyberonics, Inc. Housing for an implantable medical device
US9259569B2 (en) 2009-05-15 2016-02-16 Daniel M. Brounstein Methods, systems and devices for neuromodulating spinal anatomy
US9289612B1 (en) 2014-12-11 2016-03-22 Medtronic Inc. Coordination of ventricular pacing in a leadless pacing system
US9314618B2 (en) 2006-12-06 2016-04-19 Spinal Modulation, Inc. Implantable flexible circuit leads and methods of use
US9314633B2 (en) 2008-01-25 2016-04-19 Cyberonics, Inc. Contingent cardio-protection for epilepsy patients
FR3027232A1 (en) * 2014-10-20 2016-04-22 Melissa Estelle Berthelot A dynamic palliation cognitive deficits
US9375573B2 (en) 1998-08-05 2016-06-28 Cyberonics, Inc. Systems and methods for monitoring a patient's neurological disease state
US9399140B2 (en) 2014-07-25 2016-07-26 Medtronic, Inc. Atrial contraction detection by a ventricular leadless pacing device for atrio-synchronous ventricular pacing
US9403011B2 (en) 2014-08-27 2016-08-02 Aleva Neurotherapeutics Leadless neurostimulator
US9409013B2 (en) 2009-10-20 2016-08-09 Nyxoah SA Method for controlling energy delivery as a function of degree of coupling
US9415215B2 (en) 2009-10-20 2016-08-16 Nyxoah SA Methods for treatment of sleep apnea
US9415222B2 (en) 1998-08-05 2016-08-16 Cyberonics, Inc. Monitoring an epilepsy disease state with a supervisory module
US9421373B2 (en) 1998-08-05 2016-08-23 Cyberonics, Inc. Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US9427570B2 (en) 2006-12-06 2016-08-30 St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”) Expandable stimulation leads and methods of use
US9474894B2 (en) 2014-08-27 2016-10-25 Aleva Neurotherapeutics Deep brain stimulation lead
US9492668B2 (en) 2014-11-11 2016-11-15 Medtronic, Inc. Mode switching by a ventricular leadless pacing device
US9492669B2 (en) 2014-11-11 2016-11-15 Medtronic, Inc. Mode switching by a ventricular leadless pacing device
US9549708B2 (en) 2010-04-01 2017-01-24 Ecole Polytechnique Federale De Lausanne Device for interacting with neurological tissue and methods of making and using the same
US9623234B2 (en) 2014-11-11 2017-04-18 Medtronic, Inc. Leadless pacing device implantation
US9622675B2 (en) 2007-01-25 2017-04-18 Cyberonics, Inc. Communication error alerting in an epilepsy monitoring system
US9643019B2 (en) 2010-02-12 2017-05-09 Cyberonics, Inc. Neurological monitoring and alerts
US9717439B2 (en) 2010-03-31 2017-08-01 Medtronic, Inc. Patient data display
US9724519B2 (en) 2014-11-11 2017-08-08 Medtronic, Inc. Ventricular leadless pacing device mode switching
US9788744B2 (en) 2007-07-27 2017-10-17 Cyberonics, Inc. Systems for monitoring brain activity and patient advisory device
US9898656B2 (en) 2007-01-25 2018-02-20 Cyberonics, Inc. Systems and methods for identifying a contra-ictal condition in a subject
US9925376B2 (en) 2014-08-27 2018-03-27 Aleva Neurotherapeutics Treatment of autoimmune diseases with deep brain stimulation

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US7640062B2 (en) * 2000-05-08 2009-12-29 Brainsgate Ltd. Methods and systems for management of alzheimer's disease
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US7146209B2 (en) 2000-05-08 2006-12-05 Brainsgate, Ltd. Stimulation for treating eye pathologies
US7561919B2 (en) 2002-11-14 2009-07-14 Brainsgate Ltd. SPG stimulation via the greater palatine canal
US7672730B2 (en) 2001-03-08 2010-03-02 Advanced Neuromodulation Systems, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US7831305B2 (en) 2001-10-15 2010-11-09 Advanced Neuromodulation Systems, Inc. Neural stimulation system and method responsive to collateral neural activity
US7756584B2 (en) 2000-07-13 2010-07-13 Advanced Neuromodulation Systems, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US7305268B2 (en) 2000-07-13 2007-12-04 Northstar Neurscience, Inc. Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators
US7010351B2 (en) 2000-07-13 2006-03-07 Northstar Neuroscience, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
JP2002134911A (en) * 2000-10-16 2002-05-10 Internatl Business Mach Corp <Ibm> Method for manufacturing circuit board having conducting via
US7493172B2 (en) * 2001-01-30 2009-02-17 Boston Scientific Neuromodulation Corp. Methods and systems for stimulating a nerve originating in an upper cervical spine area to treat a medical condition
US20060064140A1 (en) * 2001-01-30 2006-03-23 Whitehurst Todd K Methods and systems for stimulating a trigeminal nerve to treat a psychiatric disorder
US7167751B1 (en) 2001-03-01 2007-01-23 Advanced Bionics Corporation Method of using a fully implantable miniature neurostimulator for vagus nerve stimulation
US7221981B2 (en) 2002-03-28 2007-05-22 Northstar Neuroscience, Inc. Electrode geometries for efficient neural stimulation
US20060009815A1 (en) * 2002-05-09 2006-01-12 Boveja Birinder R Method and system to provide therapy or alleviate symptoms of involuntary movement disorders by providing complex and/or rectangular electrical pulses to vagus nerve(s)
US7003352B1 (en) * 2002-05-24 2006-02-21 Advanced Bionics Corporation Treatment of epilepsy by brain stimulation
US6934580B1 (en) * 2002-07-20 2005-08-23 Flint Hills Scientific, L.L.C. Stimulation methodologies and apparatus for control of brain states
US20050075680A1 (en) 2003-04-18 2005-04-07 Lowry David Warren Methods and systems for intracranial neurostimulation and/or sensing
US7236830B2 (en) 2002-12-10 2007-06-26 Northstar Neuroscience, Inc. Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of Parkinson's disease and/or other movement disorders
US7155279B2 (en) 2003-03-28 2006-12-26 Advanced Bionics Corporation Treatment of movement disorders with drug therapy
US7684866B2 (en) 2003-08-01 2010-03-23 Advanced Neuromodulation Systems, Inc. Apparatus and methods for applying neural stimulation to a patient
US8630713B2 (en) * 2003-09-16 2014-01-14 Myotronics-Noromed, Inc. Electrical muscle stimulator
US9050469B1 (en) 2003-11-26 2015-06-09 Flint Hills Scientific, Llc Method and system for logging quantitative seizure information and assessing efficacy of therapy using cardiac signals
WO2005062829A3 (en) * 2003-12-19 2005-10-06 Advanced Bionics Corp Skull-mounted electrical stimulation system and method for treating patients
WO2006019764A3 (en) 2004-07-15 2006-12-07 Northstar Neuroscience Inc Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
US7711432B2 (en) * 2004-07-26 2010-05-04 Advanced Neuromodulation Systems, Inc. Stimulation system and method for treating a neurological disorder
US9205261B2 (en) 2004-09-08 2015-12-08 The Board Of Trustees Of The Leland Stanford Junior University Neurostimulation methods and systems
US20120277839A1 (en) 2004-09-08 2012-11-01 Kramer Jeffery M Selective stimulation to modulate the sympathetic nervous system
WO2006047264A1 (en) * 2004-10-21 2006-05-04 Advanced Neuromodulation Systems, Inc. Peripheral nerve stimulation to treat auditory dysfunction
US7565200B2 (en) * 2004-11-12 2009-07-21 Advanced Neuromodulation Systems, Inc. Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects
US8248232B2 (en) * 2006-01-25 2012-08-21 Greatbatch Ltd. Hermetically sealed RFID microelectronic chip connected to a biocompatible RFID antenna
US20070118197A1 (en) * 2005-07-12 2007-05-24 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern Californ Probe for Identifying Injection Site for Deep Brain Neural Prostheses
US8660647B2 (en) * 2005-07-28 2014-02-25 Cyberonics, Inc. Stimulating cranial nerve to treat pulmonary disorder
US7706874B2 (en) 2005-07-28 2010-04-27 Cyberonics, Inc. Stimulating cranial nerve to treat disorders associated with the thyroid gland
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
US8929991B2 (en) 2005-10-19 2015-01-06 Advanced Neuromodulation Systems, Inc. Methods for establishing parameters for neural stimulation, including via performance of working memory tasks, and associated kits
US7729773B2 (en) 2005-10-19 2010-06-01 Advanced Neuromodualation Systems, Inc. Neural stimulation and optical monitoring systems and methods
US7596414B2 (en) * 2005-12-05 2009-09-29 Boston Scientific Neuromodulation Corporation Cuff electrode arrangement for nerve stimulation and methods of treating disorders
US7610103B2 (en) * 2005-12-19 2009-10-27 Boston Scientific Neuromodulation Corporation Electrode arrangement for nerve stimulation and methods of treating disorders
WO2007075477A3 (en) * 2005-12-19 2008-12-04 Univ Florida Closed-loop state-dependent seizure prevention systems
US7570999B2 (en) 2005-12-20 2009-08-04 Cardiac Pacemakers, Inc. Implantable device for treating epilepsy and cardiac rhythm disorders
US7657310B2 (en) 2006-01-26 2010-02-02 Cyberonics, Inc. Treatment of reproductive endocrine disorders by vagus nerve stimulation
CA2641821C (en) * 2006-02-16 2017-10-10 Imthera Medical, Inc. An rfid-based apparatus, system, and method for therapeutic treatment of a patient
US7953498B1 (en) 2006-03-15 2011-05-31 Boston Scientific Neuromodulation Corporation Resorbable anchor arrangements for implantable devices and methods of making and using
US7974706B2 (en) * 2006-03-30 2011-07-05 Boston Scientific Neuromodulation Corporation Electrode contact configurations for cuff leads
US8000797B1 (en) 2006-06-07 2011-08-16 Advanced Bionics, Llc Systems and methods for providing neural stimulation with an asynchronous stochastic strategy
US8244377B1 (en) 2006-09-27 2012-08-14 Boston Scientific Neuromodulation Corporation Fixation arrangements for implantable leads and methods of making and using
US20080091255A1 (en) * 2006-10-11 2008-04-17 Cardiac Pacemakers Implantable neurostimulator for modulating cardiovascular function
CA2671250A1 (en) 2006-12-06 2008-06-12 Spinal Modulation, Inc. Hard tissue anchors and delivery devices
US8290599B2 (en) * 2006-12-12 2012-10-16 Boston Scientific Neuromodulation Corporation Electrode arrangements for tissue stimulation and methods of use and manufacture
US7706875B2 (en) * 2007-01-25 2010-04-27 Cyberonics, Inc. Modulation of drug effects by vagus nerve stimulation
US9339643B1 (en) 2007-03-30 2016-05-17 Boston Scientific Neuromodulation Corporation Acutely stiff implantable electrodes
CA2697822A1 (en) 2007-10-09 2009-04-16 Imthera Medical, Inc. Apparatus, system, and method for selective stimulation
WO2009055000A1 (en) 2007-10-23 2009-04-30 Optima Neuroscience, Inc. System for seizure monitoring and detection
US8457757B2 (en) * 2007-11-26 2013-06-04 Micro Transponder, Inc. Implantable transponder systems and methods
WO2009070705A3 (en) * 2007-11-26 2009-08-27 Microtransponder Inc. Transfer coil architecture
DE112008003180T5 (en) * 2007-11-26 2011-03-03 Micro-Transponder, Inc., Dallas Implantable transponder systems and procedures
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US9089707B2 (en) 2008-07-02 2015-07-28 The Board Of Regents, The University Of Texas System Systems, methods and devices for paired plasticity
US20100114184A1 (en) * 2008-10-07 2010-05-06 Brainsgate Ltd. Flexible tools for preparing bony canals
WO2010042404A1 (en) 2008-10-09 2010-04-15 Imthera Medical, Inc. Method of stimulating a hypoglossal nerve for controlling the position of a patient's tongue
US8417344B2 (en) 2008-10-24 2013-04-09 Cyberonics, Inc. Dynamic cranial nerve stimulation based on brain state determination from cardiac data
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US8827912B2 (en) 2009-04-24 2014-09-09 Cyberonics, Inc. Methods and systems for detecting epileptic events using NNXX, optionally with nonlinear analysis parameters
US8239028B2 (en) 2009-04-24 2012-08-07 Cyberonics, Inc. Use of cardiac parameters in methods and systems for treating a chronic medical condition
US20140358197A1 (en) 2009-10-20 2014-12-04 Adi Mashiach Arced Implant Unit for Modulation of Nerves
CA2780096A1 (en) 2009-11-10 2011-05-19 Imthera Medical, Inc. System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue
CN102791185A (en) 2009-12-21 2012-11-21 S·华 Insertion of medical devices through non-orthogonal and orthogonal trajectories within the cranium and methods of using
US8649871B2 (en) 2010-04-29 2014-02-11 Cyberonics, Inc. Validity test adaptive constraint modification for cardiac data used for detection of state changes
US8562536B2 (en) 2010-04-29 2013-10-22 Flint Hills Scientific, Llc Algorithm for detecting a seizure from cardiac data
US8831732B2 (en) 2010-04-29 2014-09-09 Cyberonics, Inc. Method, apparatus and system for validating and quantifying cardiac beat data quality
US8679009B2 (en) 2010-06-15 2014-03-25 Flint Hills Scientific, Llc Systems approach to comorbidity assessment
US8641646B2 (en) 2010-07-30 2014-02-04 Cyberonics, Inc. Seizure detection using coordinate data
US8571643B2 (en) 2010-09-16 2013-10-29 Flint Hills Scientific, Llc Detecting or validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex
US8337404B2 (en) 2010-10-01 2012-12-25 Flint Hills Scientific, Llc Detecting, quantifying, and/or classifying seizures using multimodal data
US8684921B2 (en) 2010-10-01 2014-04-01 Flint Hills Scientific Llc Detecting, assessing and managing epilepsy using a multi-variate, metric-based classification analysis
US8382667B2 (en) 2010-10-01 2013-02-26 Flint Hills Scientific, Llc Detecting, quantifying, and/or classifying seizures using multimodal data
CN103561811A (en) 2011-02-02 2014-02-05 脊髓调制公司 Devices, systems and methods for the targeted treatment of movement disorders
US9504390B2 (en) 2011-03-04 2016-11-29 Globalfoundries Inc. Detecting, assessing and managing a risk of death in epilepsy
US8725239B2 (en) 2011-04-25 2014-05-13 Cyberonics, Inc. Identifying seizures using heart rate decrease
US9402550B2 (en) 2011-04-29 2016-08-02 Cybertronics, Inc. Dynamic heart rate threshold for neurological event detection
WO2014057361A3 (en) 2012-07-26 2014-07-24 Adi Mashiach Implant holder and suture guide
CN105873637A (en) 2013-06-17 2016-08-17 尼科索亚股份有限公司 Dynamic modification of modulation throughout a therapy period
US9675796B2 (en) 2013-11-10 2017-06-13 Brainsgate Ltd. Implant and delivery system for neural stimulator

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5575813A (en) * 1992-09-11 1996-11-19 Massachusetts Institute Of Technology Low-pressure neural contact structure
US6415184B1 (en) * 1999-01-06 2002-07-02 Ball Semiconductor, Inc. Implantable neuro-stimulator with ball implant

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4702254A (en) 1983-09-14 1987-10-27 Jacob Zabara Neurocybernetic prosthesis
US4867164A (en) 1983-09-14 1989-09-19 Jacob Zabara Neurocybernetic prosthesis
US5215086A (en) 1991-05-03 1993-06-01 Cyberonics, Inc. Therapeutic treatment of migraine symptoms by stimulation
US5312439A (en) 1991-12-12 1994-05-17 Loeb Gerald E Implantable device having an electrolytic storage electrode
US5193540A (en) 1991-12-18 1993-03-16 Alfred E. Mann Foundation For Scientific Research Structure and method of manufacture of an implantable microstimulator
US5193539A (en) 1991-12-18 1993-03-16 Alfred E. Mann Foundation For Scientific Research Implantable microstimulator
US5540734A (en) 1994-09-28 1996-07-30 Zabara; Jacob Cranial nerve stimulation treatments using neurocybernetic prosthesis
US6051017A (en) 1996-02-20 2000-04-18 Advanced Bionics Corporation Implantable microstimulator and systems employing the same
WO1998037926A1 (en) 1997-02-26 1998-09-03 Alfred E. Mann Foundation For Scientific Research Battery-powered patient implantable device
EP1011804B1 (en) 1997-03-27 2009-08-19 Alfred E. Mann Foundation System of implantable devices for monitoring and/or affecting body parameters
US6205359B1 (en) 1998-10-26 2001-03-20 Birinder Bob Boveja Apparatus and method for adjunct (add-on) therapy of partial complex epilepsy, generalized epilepsy and involuntary movement disorders utilizing an external stimulator
US6161044A (en) 1998-11-23 2000-12-12 Synaptic Corporation Method and apparatus for treating chronic pain syndromes, tremor, dementia and related disorders and for inducing electroanesthesia using high frequency, high intensity transcutaneous electrical nerve stimulation
US6464687B1 (en) 1999-03-09 2002-10-15 Ball Semiconductor, Inc. Implantable drug delivery system
US6526318B1 (en) 2000-06-16 2003-02-25 Mehdi M. Ansarinia Stimulation method for the sphenopalatine ganglia, sphenopalatine nerve, or vidian nerve for treatment of medical conditions
US6405079B1 (en) 2000-09-22 2002-06-11 Mehdi M. Ansarinia Stimulation method for the dural venous sinuses and adjacent dura for treatment of medical conditions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5575813A (en) * 1992-09-11 1996-11-19 Massachusetts Institute Of Technology Low-pressure neural contact structure
US6415184B1 (en) * 1999-01-06 2002-07-02 Ball Semiconductor, Inc. Implantable neuro-stimulator with ball implant

Cited By (238)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7930035B2 (en) 1998-08-05 2011-04-19 Neurovista Corporation Providing output indicative of subject's disease state
US7747325B2 (en) 1998-08-05 2010-06-29 Neurovista Corporation Systems and methods for monitoring a patient's neurological disease state
US7853329B2 (en) 1998-08-05 2010-12-14 Neurovista Corporation Monitoring efficacy of neural modulation therapy
US9375573B2 (en) 1998-08-05 2016-06-28 Cyberonics, Inc. Systems and methods for monitoring a patient's neurological disease state
US9113801B2 (en) 1998-08-05 2015-08-25 Cyberonics, Inc. Methods and systems for continuous EEG monitoring
US9415222B2 (en) 1998-08-05 2016-08-16 Cyberonics, Inc. Monitoring an epilepsy disease state with a supervisory module
US9421373B2 (en) 1998-08-05 2016-08-23 Cyberonics, Inc. Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US9042988B2 (en) 1998-08-05 2015-05-26 Cyberonics, Inc. Closed-loop vagus nerve stimulation
US8781597B2 (en) 1998-08-05 2014-07-15 Cyberonics, Inc. Systems for monitoring a patient's neurological disease state
US8762065B2 (en) 1998-08-05 2014-06-24 Cyberonics, Inc. Closed-loop feedback-driven neuromodulation
US9320900B2 (en) 1998-08-05 2016-04-26 Cyberonics, Inc. Methods and systems for determining subject-specific parameters for a neuromodulation therapy
US8600494B2 (en) 1999-04-09 2013-12-03 Ionix Medical Inc. Method and device for treating abnormal tissue growth with electrical therapy
US20090024075A1 (en) * 1999-04-09 2009-01-22 Schroeppel Edward A Method and Device for Treating Abnormal Tissue Growth With Electrical Therapy
US8014854B2 (en) 1999-04-09 2011-09-06 Ionix Medical Inc. Method and device for treating abnormal tissue growth with electrical therapy
US7742811B2 (en) 2000-03-13 2010-06-22 Onco Stim Implantable device and method for the electrical treatment of cancer
US20040254618A1 (en) * 2000-03-13 2004-12-16 Schroeppel Edward A. Implantable device and method for the electrical treatment of cancer
US20050004507A1 (en) * 2000-03-13 2005-01-06 Oncostim. Inc. Method and device for treating cancer with electrical therapy in conjunction with chemotherapeutic agents and radiation therapy
US8024048B2 (en) 2000-03-13 2011-09-20 Ionix Medical Inc. Method and device for treating cancer with electrical therapy in conjunction with chemotherapeutic agents and radiation therapy
US7890177B1 (en) 2000-04-07 2011-02-15 Boston Scientific Neuromodulation Corporation Device and therapy for erectile dysfunction and other sexual dysfunction
US7865243B1 (en) 2000-04-07 2011-01-04 Boston Scientific Neuromodulation Corporation Device and therapy for erectile dysfunction and other sexual dysfunction
US20050209652A1 (en) * 2001-04-26 2005-09-22 Whitehurst Todd K Methods and systems for electrical and/or drug stimulation as a therapy for erectile dysfunction
US7660631B2 (en) 2001-04-26 2010-02-09 Boston Scientific Neuromodulation Corporation Methods and systems for electrical and/or drug stimulation as a therapy for erectile dysfunction
US7308303B2 (en) 2001-11-01 2007-12-11 Advanced Bionics Corporation Thrombolysis and chronic anticoagulation therapy
US7877137B2 (en) 2001-11-01 2011-01-25 Boston Scientific Neuromodulation Corporation Thrombolysis and chronic anticoagulation therapy
US20030083698A1 (en) * 2001-11-01 2003-05-01 Whitehurst Todd K. Thrombolysis and chronic anticoagulation therapy
US20080286327A1 (en) * 2001-11-01 2008-11-20 Whitehurst Todd K Thombolysis and chronic anticoagulation therapy
US20100331807A1 (en) * 2002-05-24 2010-12-30 Boston Scientific Neuromodulation Corporation Treatment of movement disorders by brain stimulation
US8401634B2 (en) 2002-05-24 2013-03-19 Boston Scientific Neuromodulation Corporation Treatment of movement disorders by brain stimulation
US20070021800A1 (en) * 2002-06-20 2007-01-25 Advanced Bionics Corporation, A California Corporation Cavernous nerve stimulation via unidirectional propagation of action potentials
US7783362B2 (en) 2002-06-20 2010-08-24 Boston Scientific Neuromodulation Corporation Vagus nerve stimulation via unidirectional propagation of action potentials
US20030236558A1 (en) * 2002-06-20 2003-12-25 Whitehurst Todd K. Vagus nerve stimulation via unidirectional propagation of action potentials
US7860570B2 (en) 2002-06-20 2010-12-28 Boston Scientific Neuromodulation Corporation Implantable microstimulators and methods for unidirectional propagation of action potentials
US20030236557A1 (en) * 2002-06-20 2003-12-25 Whitehurst Todd K. Cavernous nerve stimulation via unidirectional propagation of action potentials
US20040015205A1 (en) * 2002-06-20 2004-01-22 Whitehurst Todd K. Implantable microstimulators with programmable multielectrode configuration and uses thereof
US7292890B2 (en) * 2002-06-20 2007-11-06 Advanced Bionics Corporation Vagus nerve stimulation via unidirectional propagation of action potentials
US20040015204A1 (en) * 2002-06-20 2004-01-22 Whitehurst Todd K. Implantable microstimulators and methods for unidirectional propagation of action potentials
US8712547B2 (en) 2002-06-20 2014-04-29 Boston Scientific Neuromodulation Corporation Cavernous nerve stimulation via unidirectional propagation of action potentials
US7899539B2 (en) 2002-06-20 2011-03-01 Boston Scientific Neuromodulation Corporation Cavernous nerve stimulation via unidirectional propagation of action potentials
US8548604B2 (en) 2002-06-20 2013-10-01 Boston Scientific Neuromodulation Corporation Implantable microstimulators and methods for unidirectional propagation of action potentials
US9409028B2 (en) 2002-06-20 2016-08-09 Boston Scientific Neuromodulation Corporation Implantable microstimulators with programmable multielectrode configuration and uses thereof
US7203548B2 (en) 2002-06-20 2007-04-10 Advanced Bionics Corporation Cavernous nerve stimulation via unidirectional propagation of action potentials
US9283394B2 (en) 2002-06-20 2016-03-15 Boston Scientific Neuromodulation Corporation Implantable microstimulators and methods for unidirectional propagation of action potentials
US20050222646A1 (en) * 2004-04-06 2005-10-06 Kai Kroll Method and device for treating cancer with modified output electrical therapy
US20050222623A1 (en) * 2004-04-06 2005-10-06 Oncostim Inc., A Minnesota Corporation Partially implantable system for the electrical treatment of cancer
US7720549B2 (en) * 2004-04-06 2010-05-18 Oncostim, Inc. Partially implantable system for the electrical treatment of abnormal tissue growth
US20060052839A1 (en) * 2004-09-08 2006-03-09 Kim Daniel H Methods for stimulating a dorsal root ganglion
US7450993B2 (en) 2004-09-08 2008-11-11 Spinal Modulation, Inc. Methods for selective stimulation of a ganglion
US7447546B2 (en) 2004-09-08 2008-11-04 Spinal Modulation, Inc. Methods of neurostimulating targeted neural tissue
US8229565B2 (en) 2004-09-08 2012-07-24 Spinal Modulation, Inc. Methods for stimulating a dorsal root ganglion
US7580753B2 (en) 2004-09-08 2009-08-25 Spinal Modulation, Inc. Method and system for stimulating a dorsal root ganglion
US8082039B2 (en) 2004-09-08 2011-12-20 Spinal Modulation, Inc. Stimulation systems
US20060052837A1 (en) * 2004-09-08 2006-03-09 Kim Daniel H Methods and systems for modulating neural tissue
US20060052827A1 (en) * 2004-09-08 2006-03-09 Kim Daniel H Stimulation systems
US20060052836A1 (en) * 2004-09-08 2006-03-09 Kim Daniel H Neurostimulation system
US7502651B2 (en) 2004-09-08 2009-03-10 Spinal Modulation, Inc. Methods for stimulating a dorsal root ganglion
US7337006B2 (en) 2004-09-08 2008-02-26 Spinal Modulation, Inc. Methods and systems for modulating neural tissue
US7337005B2 (en) 2004-09-08 2008-02-26 Spinal Modulations, Inc. Methods for stimulating a nerve root ganglion
US8712546B2 (en) 2004-09-08 2014-04-29 Spinal Modulation, Inc. Neurostimulation system
US20060052828A1 (en) * 2004-09-08 2006-03-09 Kim Daniel H Methods for stimulating a nerve root ganglion
US20060052856A1 (en) * 2004-09-08 2006-03-09 Kim Daniel H Stimulation components
US20060052838A1 (en) * 2004-09-08 2006-03-09 Kim Daniel H Methods of neurostimulating targeted neural tissue
US20060052835A1 (en) * 2004-09-08 2006-03-09 Kim Daniel H Methods for stimulating the spinal cord and nervous system
US20060052826A1 (en) * 2004-09-08 2006-03-09 Kim Daniel H Pulse generator for high impedance electrodes
US8825166B2 (en) 2005-01-21 2014-09-02 John Sasha John Multiple-symptom medical treatment with roving-based neurostimulation
US20070142874A1 (en) * 2005-01-21 2007-06-21 John Michael S Multiple-symptom medical treatment with roving-based neurostimulation.
US20060149337A1 (en) * 2005-01-21 2006-07-06 John Michael S Systems and methods for tissue stimulation in medical treatment
US8788044B2 (en) 2005-01-21 2014-07-22 Michael Sasha John Systems and methods for tissue stimulation in medical treatment
US9586047B2 (en) 2005-01-28 2017-03-07 Cyberonics, Inc. Contingent cardio-protection for epilepsy patients
US8565867B2 (en) 2005-01-28 2013-10-22 Cyberonics, Inc. Changeable electrode polarity stimulation by an implantable medical device
US20100145428A1 (en) * 2005-02-25 2010-06-10 Advanced Neuromodulation Systems, Inc. Method of using spinal cord stimulation to treat neurological disorders or conditions
US20070060954A1 (en) * 2005-02-25 2007-03-15 Tracy Cameron Method of using spinal cord stimulation to treat neurological disorders or conditions
US7676271B2 (en) 2005-03-11 2010-03-09 Medtronic, Inc. Neurostimulation site screening
US8295936B2 (en) 2005-03-11 2012-10-23 Medtronic, Inc. Implantable neurostimulator device
WO2006098824A1 (en) * 2005-03-11 2006-09-21 Medtronic, Inc. Implantable neurostimulator device
US20070208391A1 (en) * 2005-03-11 2007-09-06 Medtronic, Inc. Neurostimulation site screening
US8620437B2 (en) 2005-03-11 2013-12-31 Medtronic, Inc. Method for delivery of electrical stimulation with bendable housing
US7555345B2 (en) 2005-03-11 2009-06-30 Medtronic, Inc. Implantable neurostimulator device
US20090234420A1 (en) * 2005-03-11 2009-09-17 Medtronic, Inc. Implantable neurostimulator device
US20090240303A1 (en) * 2005-03-11 2009-09-24 Medtronic. Inc. Method for delivery of electrical stimulation
US8744582B2 (en) 2005-03-11 2014-06-03 Medtronic, Inc. Implantable neurostimulator device with bellows-like element coupling first and second housing portions
US20070162087A1 (en) * 2005-03-11 2007-07-12 Medtronic, Inc. Neurostimulation site screening
US20100049277A1 (en) * 2005-03-11 2010-02-25 Medtronic, Inc. Implantable neurostimulator device
US20060206163A1 (en) * 2005-03-11 2006-09-14 Wahlstrand Carl D Neurostimulation site screening
US20060206162A1 (en) * 2005-03-11 2006-09-14 Wahlstrand Carl D Implantable neurostimulator device
US9149628B2 (en) 2005-03-11 2015-10-06 Medtronic, Inc. Neurostimulator for treating occipital neuralgia with housing sized and curved to conform to a subcutaneous neck region
US7231256B2 (en) 2005-03-11 2007-06-12 Medtronic, Inc. Neurostimulation site screening
US7664552B2 (en) 2005-03-11 2010-02-16 Medtronic, Inc. Neurostimulation site screening
US20110077579A1 (en) * 2005-03-24 2011-03-31 Harrison William V Cochlear implant with localized fluid transport
US7801602B2 (en) 2005-04-08 2010-09-21 Boston Scientific Neuromodulation Corporation Controlling stimulation parameters of implanted tissue stimulators
US20060229688A1 (en) * 2005-04-08 2006-10-12 Mcclure Kelly H Controlling stimulation parameters of implanted tissue stimulators
US20110112592A1 (en) * 2005-04-20 2011-05-12 Imad Libbus Neural stimulation system to prevent simultaneous energy discharges
US8831718B2 (en) 2005-04-20 2014-09-09 Cardiac Pacemakers, Inc. Neural stimulation system to prevent simultaneous energy discharges
US9504836B2 (en) 2005-05-10 2016-11-29 Cardiac Pacemakers, Inc. System and method to deliver therapy in presence of another therapy
US8805494B2 (en) 2005-05-10 2014-08-12 Cardiac Pacemakers, Inc. System and method to deliver therapy in presence of another therapy
US9393421B2 (en) 2005-05-26 2016-07-19 Boston Scientific Neuromodulation Corporation Controlling charge flow in the electrical stimulation of tissue
US7801600B1 (en) 2005-05-26 2010-09-21 Boston Scientific Neuromodulation Corporation Controlling charge flow in the electrical stimulation of tissue
US20100280575A1 (en) * 2005-05-26 2010-11-04 Boston Scientific Neuromodulation Corporation Controlling charge flow in the electrical stimulation of tissue
US20070016263A1 (en) * 2005-07-13 2007-01-18 Cyberonics, Inc. Neurostimulator with reduced size
US7711419B2 (en) 2005-07-13 2010-05-04 Cyberonics, Inc. Neurostimulator with reduced size
US20070027499A1 (en) * 2005-07-29 2007-02-01 Cyberonics, Inc. Neurostimulation device for treating mood disorders
US20070027500A1 (en) * 2005-07-29 2007-02-01 Cyberonics, Inc. Selective neurostimulation for treating mood disorders
US7532935B2 (en) 2005-07-29 2009-05-12 Cyberonics, Inc. Selective neurostimulation for treating mood disorders
US7499752B2 (en) 2005-07-29 2009-03-03 Cyberonics, Inc. Selective nerve stimulation for the treatment of eating disorders
US7555344B2 (en) 2005-10-28 2009-06-30 Cyberonics, Inc. Selective neurostimulation for treating epilepsy
US7729758B2 (en) 2005-11-30 2010-06-01 Boston Scientific Neuromodulation Corporation Magnetically coupled microstimulators
US9592004B2 (en) 2005-12-28 2017-03-14 Cyberonics, Inc. Methods and systems for managing epilepsy and other neurological disorders
US8868172B2 (en) 2005-12-28 2014-10-21 Cyberonics, Inc. Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
US8725243B2 (en) 2005-12-28 2014-05-13 Cyberonics, Inc. Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US9044188B2 (en) 2005-12-28 2015-06-02 Cyberonics, Inc. Methods and systems for managing epilepsy and other neurological disorders
US7801601B2 (en) 2006-01-27 2010-09-21 Cyberonics, Inc. Controlling neuromodulation using stimulus modalities
US9289599B2 (en) 2006-03-29 2016-03-22 Dignity Health Vagus nerve stimulation method
US8219188B2 (en) 2006-03-29 2012-07-10 Catholic Healthcare West Synchronization of vagus nerve stimulation with the cardiac cycle of a patient
US8280505B2 (en) 2006-03-29 2012-10-02 Catholic Healthcare West Vagus nerve stimulation method
US8150508B2 (en) 2006-03-29 2012-04-03 Catholic Healthcare West Vagus nerve stimulation method
US8660666B2 (en) 2006-03-29 2014-02-25 Catholic Healthcare West Microburst electrical stimulation of cranial nerves for the treatment of medical conditions
US9533151B2 (en) 2006-03-29 2017-01-03 Dignity Health Microburst electrical stimulation of cranial nerves for the treatment of medical conditions
US8615309B2 (en) 2006-03-29 2013-12-24 Catholic Healthcare West Microburst electrical stimulation of cranial nerves for the treatment of medical conditions
US9108041B2 (en) 2006-03-29 2015-08-18 Dignity Health Microburst electrical stimulation of cranial nerves for the treatment of medical conditions
US8738126B2 (en) 2006-03-29 2014-05-27 Catholic Healthcare West Synchronization of vagus nerve stimulation with the cardiac cycle of a patient
US7869885B2 (en) 2006-04-28 2011-01-11 Cyberonics, Inc Threshold optimization for tissue stimulation therapy
US7803148B2 (en) 2006-06-09 2010-09-28 Neurosystec Corporation Flow-induced delivery from a drug mass
US8298176B2 (en) 2006-06-09 2012-10-30 Neurosystec Corporation Flow-induced delivery from a drug mass
US20080033502A1 (en) * 2006-06-23 2008-02-07 Neurovista Corporation A Delaware Corporation Minimally Invasive System for Selecting Patient-Specific Therapy Parameters
US9480845B2 (en) 2006-06-23 2016-11-01 Cyberonics, Inc. Nerve stimulation device with a wearable loop antenna
US7676263B2 (en) * 2006-06-23 2010-03-09 Neurovista Corporation Minimally invasive system for selecting patient-specific therapy parameters
US7869867B2 (en) 2006-10-27 2011-01-11 Cyberonics, Inc. Implantable neurostimulator with refractory stimulation
US8295934B2 (en) 2006-11-14 2012-10-23 Neurovista Corporation Systems and methods of reducing artifact in neurological stimulation systems
US8855775B2 (en) 2006-11-14 2014-10-07 Cyberonics, Inc. Systems and methods of reducing artifact in neurological stimulation systems
US9427570B2 (en) 2006-12-06 2016-08-30 St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”) Expandable stimulation leads and methods of use
US9314618B2 (en) 2006-12-06 2016-04-19 Spinal Modulation, Inc. Implantable flexible circuit leads and methods of use
US8983624B2 (en) 2006-12-06 2015-03-17 Spinal Modulation, Inc. Delivery devices, systems and methods for stimulating nerve tissue on multiple spinal levels
US9622675B2 (en) 2007-01-25 2017-04-18 Cyberonics, Inc. Communication error alerting in an epilepsy monitoring system
US9898656B2 (en) 2007-01-25 2018-02-20 Cyberonics, Inc. Systems and methods for identifying a contra-ictal condition in a subject
US9044592B2 (en) 2007-01-29 2015-06-02 Spinal Modulation, Inc. Sutureless lead retention features
US9445730B2 (en) 2007-03-21 2016-09-20 Cyberonics, Inc. Implantable systems and methods for identifying a contra-ictal condition in a subject
US8543199B2 (en) 2007-03-21 2013-09-24 Cyberonics, Inc. Implantable systems and methods for identifying a contra-ictal condition in a subject
US8036736B2 (en) 2007-03-21 2011-10-11 Neuro Vista Corporation Implantable systems and methods for identifying a contra-ictal condition in a subject
US7962214B2 (en) 2007-04-26 2011-06-14 Cyberonics, Inc. Non-surgical device and methods for trans-esophageal vagus nerve stimulation
US7904175B2 (en) 2007-04-26 2011-03-08 Cyberonics, Inc. Trans-esophageal vagus nerve stimulation
US7869884B2 (en) 2007-04-26 2011-01-11 Cyberonics, Inc. Non-surgical device and methods for trans-esophageal vagus nerve stimulation
US7974701B2 (en) 2007-04-27 2011-07-05 Cyberonics, Inc. Dosing limitation for an implantable medical device
US8306627B2 (en) 2007-04-27 2012-11-06 Cyberonics, Inc. Dosing limitation for an implantable medical device
US9788744B2 (en) 2007-07-27 2017-10-17 Cyberonics, Inc. Systems for monitoring brain activity and patient advisory device
US7877136B1 (en) 2007-09-28 2011-01-25 Boston Scientific Neuromodulation Corporation Enhancement of neural signal transmission through damaged neural tissue via hyperpolarizing electrical stimulation current
US20090112282A1 (en) * 2007-10-26 2009-04-30 Medtronic, Inc. Occipital nerve stimulation
US9427572B2 (en) 2007-10-26 2016-08-30 Medtronic, Inc. Implantable medical device with connector blocks
US9008782B2 (en) 2007-10-26 2015-04-14 Medtronic, Inc. Occipital nerve stimulation
US9259591B2 (en) 2007-12-28 2016-02-16 Cyberonics, Inc. Housing for an implantable medical device
US9314633B2 (en) 2008-01-25 2016-04-19 Cyberonics, Inc. Contingent cardio-protection for epilepsy patients
US20090270943A1 (en) * 2008-04-25 2009-10-29 Maschino Steven E Blocking Exogenous Action Potentials by an Implantable Medical Device
US8204603B2 (en) 2008-04-25 2012-06-19 Cyberonics, Inc. Blocking exogenous action potentials by an implantable medical device
US8788042B2 (en) 2008-07-30 2014-07-22 Ecole Polytechnique Federale De Lausanne (Epfl) Apparatus and method for optimized stimulation of a neurological target
US9072906B2 (en) 2008-07-30 2015-07-07 Ecole Polytechnique Federale De Lausanne Apparatus and method for optimized stimulation of a neurological target
US20100030227A1 (en) * 2008-07-31 2010-02-04 Medtronic, Inc. Medical lead implantation
US20100049192A1 (en) * 2008-08-20 2010-02-25 Ionix Medical, Inc. Catheter for Treating Tissue with Non-Thermal Ablation
US20100049031A1 (en) * 2008-08-20 2010-02-25 Ionix Medical, Inc. Non-Thermal Ablation System for Treating BPH and Other Growths
US9597145B2 (en) 2008-08-20 2017-03-21 Prostacare Pty Ltd Non-thermal ablation system for treating tissue
US9211155B2 (en) 2008-08-20 2015-12-15 Prostacare Pty Ltd. Non-thermal ablation system for treating BPH and other growths
US20100049188A1 (en) * 2008-08-20 2010-02-25 Ionix Medical, Inc. Non-Thermal Ablation System for Treating Tissue
US8457747B2 (en) 2008-10-20 2013-06-04 Cyberonics, Inc. Neurostimulation with signal duration determined by a cardiac cycle
US8874218B2 (en) 2008-10-20 2014-10-28 Cyberonics, Inc. Neurostimulation with signal duration determined by a cardiac cycle
US9056197B2 (en) 2008-10-27 2015-06-16 Spinal Modulation, Inc. Selective stimulation systems and signal parameters for medical conditions
US20100121214A1 (en) * 2008-11-11 2010-05-13 Medtronic, Inc. Seizure disorder evaluation based on intracranial pressure and patient motion
US20100121213A1 (en) * 2008-11-11 2010-05-13 Medtronic, Inc. Seizure disorder evaluation based on intracranial pressure and patient motion
US20100121215A1 (en) * 2008-11-11 2010-05-13 Medtronic, Inc. Seizure detection algorithm adjustment
US8788064B2 (en) 2008-11-12 2014-07-22 Ecole Polytechnique Federale De Lausanne Microfabricated neurostimulation device
US9440082B2 (en) 2008-11-12 2016-09-13 Ecole Polytechnique Federale De Lausanne Microfabricated neurostimulation device
US8849390B2 (en) 2008-12-29 2014-09-30 Cyberonics, Inc. Processing for multi-channel signals
US8588933B2 (en) 2009-01-09 2013-11-19 Cyberonics, Inc. Medical lead termination sleeve for implantable medical devices
US9289595B2 (en) 2009-01-09 2016-03-22 Cyberonics, Inc. Medical lead termination sleeve for implantable medical devices
US8380318B2 (en) 2009-03-24 2013-02-19 Spinal Modulation, Inc. Pain management with stimulation subthreshold to paresthesia
US20100280336A1 (en) * 2009-04-30 2010-11-04 Medtronic, Inc. Anxiety disorder monitoring
US9259569B2 (en) 2009-05-15 2016-02-16 Daniel M. Brounstein Methods, systems and devices for neuromodulating spinal anatomy
US8786624B2 (en) 2009-06-02 2014-07-22 Cyberonics, Inc. Processing for multi-channel signals
JP2013506533A (en) * 2009-10-05 2013-02-28 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Apparatus for the treatment of neuropsychiatric disorders, systems and methods
US9511223B2 (en) 2009-10-05 2016-12-06 The Regents Of The University Of California Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders
US9504827B2 (en) 2009-10-05 2016-11-29 The Regents Of The University Of California Systems, devices and methods for the treatment of neurological disorders and conditions
US9238139B2 (en) 2009-10-05 2016-01-19 The Regents Of The University Of California Devices, systems and methods for treatment of neuropsychiatric disorders
JP2013506534A (en) * 2009-10-05 2013-02-28 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Extracranial implantable device for treating a neurological disorder, a system and method
US9682236B2 (en) 2009-10-05 2017-06-20 The Regents Of The University Of California Devices, systems and methods for treatment of neuropsychiatric disorders
US8577464B2 (en) 2009-10-20 2013-11-05 Nyxoah SA Apparatus and methods for feedback-based nerve modulation
US9415216B2 (en) 2009-10-20 2016-08-16 Nyxoah SA Devices for treatment of sleep apnea
US8577472B2 (en) 2009-10-20 2013-11-05 Nyxoah SA Systems and methods for determining a sleep disorder based on positioning of the tongue
US9415215B2 (en) 2009-10-20 2016-08-16 Nyxoah SA Methods for treatment of sleep apnea
US8574164B2 (en) 2009-10-20 2013-11-05 Nyxoah SA Apparatus and method for detecting a sleep disordered breathing precursor
US20110093036A1 (en) * 2009-10-20 2011-04-21 Nyxoah SA Implantable Electrical Stimulator
US9550064B2 (en) 2009-10-20 2017-01-24 Adi Mashiach Apparatus and methods for feedback-based nerve modulation
US9409013B2 (en) 2009-10-20 2016-08-09 Nyxoah SA Method for controlling energy delivery as a function of degree of coupling
US8774937B2 (en) 2009-12-01 2014-07-08 Ecole Polytechnique Federale De Lausanne Microfabricated surface neurostimulation device and methods of making and using the same
US9192767B2 (en) 2009-12-01 2015-11-24 Ecole Polytechnique Federale De Lausanne Microfabricated surface neurostimulation device and methods of making and using the same
US9604055B2 (en) 2009-12-01 2017-03-28 Ecole Polytechnique Federale De Lausanne Microfabricated surface neurostimulation device and methods of making and using the same
US20110152965A1 (en) * 2009-12-21 2011-06-23 Nyxoah SA Diagnosis and Prediction of Obstructive Sleep Apnea
US8585617B2 (en) 2009-12-21 2013-11-19 Nyxoah SA Diagnosis and prediction of obstructive sleep apnea
US9643019B2 (en) 2010-02-12 2017-05-09 Cyberonics, Inc. Neurological monitoring and alerts
US9717439B2 (en) 2010-03-31 2017-08-01 Medtronic, Inc. Patient data display
US9549708B2 (en) 2010-04-01 2017-01-24 Ecole Polytechnique Federale De Lausanne Device for interacting with neurological tissue and methods of making and using the same
US9358392B2 (en) 2011-09-30 2016-06-07 Adi Mashiach Electrode configuration for implantable modulator
US9403009B2 (en) 2011-09-30 2016-08-02 Nyxoah SA Apparatus and methods for implant coupling indication
US9302093B2 (en) * 2011-09-30 2016-04-05 Nyxoah SA Devices and methods for delivering energy as a function of condition severity
US20130085541A1 (en) * 2011-09-30 2013-04-04 Adi Mashiach Devices and Methods for Delivering Energy as a Function of Condition Severity
US9895540B2 (en) 2011-09-30 2018-02-20 Nyxoah SA Devices and methods for low current neural modulation
US8588941B2 (en) 2011-09-30 2013-11-19 Nyxoah SA Device and method for modulating nerves using parallel electric fields
US9314613B2 (en) 2011-09-30 2016-04-19 Adi Mashiach Apparatus and methods for modulating nerves using parallel electric fields
US9421372B2 (en) 2011-09-30 2016-08-23 Adi Mashiach Head pain management device having an antenna
WO2013061169A3 (en) * 2011-09-30 2013-07-25 Adi Mashiach Antenna providing variable communication with an implant
US9061151B2 (en) 2011-09-30 2015-06-23 Adi Mashiach Apparatus and method to control an implant
EP2760538A4 (en) * 2011-09-30 2015-06-10 Adi Mashiach Antenna providing variable communication with an implant
US8577478B2 (en) 2011-09-30 2013-11-05 Nyxoah SA Antenna providing variable communication with an implant
US9044612B2 (en) 2011-09-30 2015-06-02 Adi Mashiach Apparatus and method for extending implant life using a dual power scheme
US8577466B2 (en) 2011-09-30 2013-11-05 Nyxoah SA System and method for nerve modulation using noncontacting electrodes
US8989868B2 (en) 2011-09-30 2015-03-24 Hyllio SA Apparatus and method for controlling energy delivery as a function of degree of coupling
US9649493B2 (en) 2011-09-30 2017-05-16 Adi Mashiach System and method for nerve modulation using noncontacting electrodes
US8929999B2 (en) 2011-09-30 2015-01-06 Adi Maschiach Electrode configuration for implantable modulator
US9248291B2 (en) 2011-09-30 2016-02-02 Adi Mashiach Hypertension therapy implant apparatus
US8577467B2 (en) 2011-09-30 2013-11-05 Nyxoah SA Apparatus and method for controlling energy delivery as a function of degree of coupling
CN104066477A (en) * 2011-09-30 2014-09-24 尼科索亚股份有限公司 Antenna providing variable communication with an implant
US8577468B2 (en) 2011-09-30 2013-11-05 Nyxoah SA Apparatus and method for extending implant life using a dual power scheme
US8577465B2 (en) 2011-09-30 2013-11-05 Nyxoah SA Modulator apparatus configured for implantation
US9878159B2 (en) 2011-09-30 2018-01-30 Adi Mashiach Hypertension therapy implant apparatus
US8798773B2 (en) 2011-09-30 2014-08-05 Man & Science, SA Electrode configuration for implantable modulator
US8644957B2 (en) 2011-09-30 2014-02-04 Nyxoah SA Electrode configuration for implantable modulator
US8700183B2 (en) 2011-09-30 2014-04-15 Nyxoah SA Devices and methods for low current neural modulation
WO2013061169A2 (en) * 2011-09-30 2013-05-02 Adi Mashiach Antenna providing variable communication with an implant
US8718776B2 (en) 2011-09-30 2014-05-06 Nyxoah SA Apparatus and method to control an implant
WO2016014857A1 (en) * 2014-07-23 2016-01-28 Department Of Veterans Affairs Parasympathetic activation by vagus nerve stimulation
US9399140B2 (en) 2014-07-25 2016-07-26 Medtronic, Inc. Atrial contraction detection by a ventricular leadless pacing device for atrio-synchronous ventricular pacing
US9572985B2 (en) 2014-08-27 2017-02-21 Aleva Neurotherapeutics Method of manufacturing a thin film leadless neurostimulator
US9925376B2 (en) 2014-08-27 2018-03-27 Aleva Neurotherapeutics Treatment of autoimmune diseases with deep brain stimulation
US9889304B2 (en) 2014-08-27 2018-02-13 Aleva Neurotherapeutics Leadless neurostimulator
US9474894B2 (en) 2014-08-27 2016-10-25 Aleva Neurotherapeutics Deep brain stimulation lead
US9403011B2 (en) 2014-08-27 2016-08-02 Aleva Neurotherapeutics Leadless neurostimulator
FR3027232A1 (en) * 2014-10-20 2016-04-22 Melissa Estelle Berthelot A dynamic palliation cognitive deficits
US9724519B2 (en) 2014-11-11 2017-08-08 Medtronic, Inc. Ventricular leadless pacing device mode switching
US9808628B2 (en) 2014-11-11 2017-11-07 Medtronic, Inc. Mode switching by a ventricular leadless pacing device
US9492668B2 (en) 2014-11-11 2016-11-15 Medtronic, Inc. Mode switching by a ventricular leadless pacing device
US9492669B2 (en) 2014-11-11 2016-11-15 Medtronic, Inc. Mode switching by a ventricular leadless pacing device
US9623234B2 (en) 2014-11-11 2017-04-18 Medtronic, Inc. Leadless pacing device implantation
US9289612B1 (en) 2014-12-11 2016-03-22 Medtronic Inc. Coordination of ventricular pacing in a leadless pacing system

Also Published As

Publication number Publication date Type
US6788975B1 (en) 2004-09-07 grant

Similar Documents

Publication Publication Date Title
US6879859B1 (en) External pulse generator for adjunct (add-on) treatment of obesity, eating disorders, neurological, neuropsychiatric, and urological disorders
US7706889B2 (en) Tree-based electrical stimulator programming
US7010351B2 (en) Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US5540734A (en) Cranial nerve stimulation treatments using neurocybernetic prosthesis
US6941171B2 (en) Implantable stimulator methods for treatment of incontinence and pain
US6662052B1 (en) Method and system for neuromodulation therapy using external stimulator with wireless communication capabilites
US8280515B2 (en) Occipital neuromodulation
US7483746B2 (en) Stimulation of the stomach in response to sensed parameters to treat obesity
US7353065B2 (en) Responsive therapy for psychiatric disorders
US6339725B1 (en) Methods of modulating aspects of brain neural plasticity by vagus nerve stimulation
US6721603B2 (en) Nerve stimulation as a treatment for pain
US20070255320A1 (en) Method and apparatus for forming insulated implantable electrodes
US20080027503A1 (en) Vagus Nerve Stimulation by Electrical Signals for Controlling Cerebellar Tremor
US20050240229A1 (en) Methods and systems for stimulation as a therapy for erectile dysfunction
US7610100B2 (en) Methods and systems for treating osteoarthritis
US20050177192A1 (en) Neurostimulation for affecting sleep disorders
US6885895B1 (en) Methods and systems for electrical and/or drug stimulation as a therapy for erectile dysfunction
US20070027504A1 (en) Cranial nerve stimulation to treat a hearing disorder
US20110112603A1 (en) Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders
US20030100931A1 (en) Brain signal feedback for pain management
US20060235484A1 (en) Stimulation of a stimulation site within the neck or head
US6449512B1 (en) Apparatus and method for treatment of urological disorders using programmerless implantable pulse generator system
US20130023951A1 (en) Occipital neuromodulation method
US20080139870A1 (en) Systems and methods for treating patient hypertonicity
US20070173890A1 (en) Stimulation mode adjustment for an implantable medical device

Legal Events

Date Code Title Description
AS Assignment

Owner name: ADVANCED BIONICS CORPORATION, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WHITEHURST, TODD K.;MCGLVERN, JAMES P.;KUZMA, JANUSZ A.;REEL/FRAME:012392/0055

Effective date: 20020123

AS Assignment

Owner name: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION, CAL

Free format text: CHANGE OF NAME;ASSIGNOR:ADVANCED BIONICS CORPORATION;REEL/FRAME:020405/0722

Effective date: 20071116

Owner name: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION,CALI

Free format text: CHANGE OF NAME;ASSIGNOR:ADVANCED BIONICS CORPORATION;REEL/FRAME:020405/0722

Effective date: 20071116

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12